Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
1295 Cards in this Set
- Front
- Back
Soft tissue, ewing's sarcoma & giant cell carcinoma are located |
in the lower and upper extremities |
|
isodose shiFt method is used to |
correct for contour irregularities |
|
splenic flexure is located |
at the junction of the transverse & descending colon |
|
1 mev photon is equal to |
1/10 the wave length of a 100 kev photon |
|
What does amu stand for? |
atomic unit of mass (amu) |
|
1 amu of energy is equal to |
3.391 mev |
|
electronmagnetic radiation are examples of |
xrays, radiowaves and visible light |
|
a photon is a type of energy that has |
zero mass, electomagnetic radiaiton and it travels through space at the speed of light |
|
1 curie of 226 Ra is equal to |
1G Radium |
|
1.02 mev relates to the
|
air production threshold |
|
The creation of a positron results from
|
pair production
|
|
photon and an outer shell electron interaction relates to |
compton scattering interaction
|
|
photoelectric effect results in the maximum energy transfer between a photon and _____ |
atomic electron |
|
backscatter factors are ratios of |
depth at (CAX) and air (free space)
|
|
tar is the ratios of absorbed dose at a given |
phantom depth and same point in free space |
|
TPR IS THE RATIOS OF DOSE AT A |
REFERENCE POINT IN TISSUE, TO THE SAME POINT OF DMAX |
|
MAYNEORDS F FACTOR IS An ___________ |
INVERSE SQUARE CORRECTION OF THE %DD
|
|
THE F FACTOR OR Mayneords IS A |
ROENTGEN TO CGY (OR RAD) CONVERSION FACTOR |
|
WEDGE TRASMISSION FACTOR EXPRESSES THE RATIO OF
|
DOSE RATES ON THE CAX WITH AND WITHOUT THE WEDGE |
|
WHEN SMALL FIELDS ARE USED |
THE OVERALL THICKNESS OF THE WEDGE IS NEEDED TO TILT THE CURVE |
|
ESOPHAGUS, PHARYNX AND THE MOUTH ARE LINED WITH
|
SQUAMOUS EPITHELIUM OF THE MUCOSA |
|
SPLEEN IS LOCATED
|
9TH-11TH RIB, 5 CM FROM MIDLINE IN THE LT HYPOCHONDRIUM REGION
|
|
TUMOR AND LYMPH NODE REMOVAL IS THE
|
PRINCIPLE DIFFERENCE BETWEEN MODIFIED AND RADICAL MASTECTOMY |
|
PHOTOELECTRIC EFFECT WILL BE ACCOMPANIED BY A___ |
CHARACTERISTIC XRAY EMISSION |
|
PHOTOELECTRIC EFFECT IS AN INTERACTION BETWEEN A
|
PHOTON AND PRIMARILY AN INNER SHELL ELECTRON
|
|
PHOTOELECTIC EFFECT IS CAUSED BY THE INTERACTION OF INCREASED ENERGY NEAR THE
|
BINDING ENERGY OF TEINNER ATOMIC SHELLS |
|
THE 2ND HALF-VALUE LAYER OF AN XRAY BEAMS IS |
HIGHER THAN THE 1ST HVL
|
|
THE COLLIMATOR
|
DEFINES THE BEAM
|
|
ISOCENTER IS
|
THE POINT AROUND WHICH THE SOURCE OF THE BEAM ROTATES
|
|
THE OPTIMAL TREATMENT PLAN IS
|
ONE THAT RESULTS IN A UNIFORM DOSE TO THE TUMOR AND LOWER DOSE IN ADJACENT TISSUE |
|
TLD RELEASE STORED ENERGY AS
|
LIGHT WHEN HEATED |
|
%DD IS DEPENDENT UPON
|
FIELD SIZE, DISTANCE AND BEAM ENERGY
|
|
TMR, TPR, BSF AND TAR ARE DEPENDENT OF |
SAD
|
|
%DD IS A PLOT WHICH SHOWS
|
TISSUE DEPTH AT CAX OF THE XRAY FIELD
|
|
TMR IS THE RATIO OF DOSE AT A SPECIFIED POINT IN TISSUE OR IN A PHANTOM TO |
THE DOSE AT THE DEPTH OF MAX DOSE (DMAX)
|
|
THE MOST USED ISOCENTRIC CALC METHOD IS |
TMR
|
|
ABSOLUTE DOSE RATE CALC DECREASED WHEN |
DIST INCREASES |
|
WEDGE ANGLE IS THE ANGLE WHICH AN |
ISODOSE CURVE IS TILTED AT THE CAX |
|
WEDGE FILTER IS THE
|
MOST COMMON USED BEAM MODIFYING DEVICE USED
|
|
WEDGE FILTER
|
ALTERS BEAM QUALITY CAUSING BEAM HARDING BY COMPTON SCATTERING |
|
WEDGE INSERTED IN THE BEAMS PATH WILL
|
ONLY RESHAPE THE EXISTIN ISODOSE CURVE
|
|
PLATTENING FILTERS
|
FLATTEN THE ISODOSE CURVES AT A SPECIFIED DEPTH
|
|
THE QUANTITY CALLED RADIATION EXPOSURE IS ONLY USED FOR WHICH TYPE OF BEAMS
|
PHOTON BEAMS WITH ENERGY LESS THAN 3 MEV
|
|
WHAT TYPE OF TX UNIT ACCELERATES E- BY THE PROCESS OF MAGNETIC INDUCTION |
BETATRON
|
|
WHAT TYPE OF TX UNIT IS MOUNTED FOR ISOCENTRIC TX |
RADIATION THERAPY
|
|
ISODOSE CURVES ARE |
LINES OF EQUAL ABSORBED DOSE
|
|
PNUMBRA REFLECTS
|
SOURCE SIZE AND BEAM SCATTER |
|
DOSE PROFILES ARE MEASURED BY A |
IONIZATION CHAMBER OR DIODE
|
|
BOLUS
|
EVENS OUT IRREGULAR CONTOURS AND FLATTENS THE BEAM |
|
TISSUE COMPENSATORS ARE MAINLY USE FOR |
OPPOSED FIELDS |
|
WEDGES ARE USED TO COMPANSATE FOR
|
SLOPING SKIN SURFACES
|
|
UNDER THE THIN SECTION OF THE WEDGE THE |
DOSE WILL FURTHER INCREASE |
|
THE BEST WAY TO CALCULATE THE OAR(ORGANS AT RISK) IS TO FIND THE |
PDD/%DD ALONG THE CAX |
|
WHAT TYPE OF THE TX UNIT PRODUCES AN XRAY BEAM THAT HAS A HVL OF 3MM AL |
SUPERFICIAL TX UNIT |
|
WHAT TYPE OF TX UNIT HAS A SOURCE OF HIGH-ENERGY GAMMA XRAYS |
RADIATION THERAPY |
|
WHAT TYPE OF TX UNIT HAS AN XRAY BEAM WITH A HVL OF 1.5 CU |
ORTHOVOLOTAGE TX UNIT |
|
WHAT TYPE OF TX UNIT WILL PRODUCE NEUTRONS AS A RADIATION HAZARD |
MEGAVOLTAGE TX UNIT |
|
WHAT IS THE CORRECTION FACTOR FOR THE STANDARD TEMP AND PRESSURE |
1.016 |
|
WHICH TYPE OF BEAM PRODUCES MAX DOSE AT THE SKIN SURFACE |
100 KEV XRAY BEAM |
|
A 4 MEV XRAY PHOTON BEAM WILL PRODUCE DOSE AT |
1CM OF DEPTH |
|
THE ENERGY OF THE BEAM DETERMINES _____ |
THE DEPTH WHICH EACH PERCENTAGE ISODOSE IS LOCATED |
|
THE E- ISOCURVE SHAPE |
BALLOON TO THE SIDES FOR E- BEAMS |
|
PENUMBRA IS
|
THE AREA OF TRANSITION AT THE BEAMS EDGE
|
|
ISODOSE CURVES ARE |
DEPTH DOSE
|
|
DOSE DISTRIBUTION DEPENDS ON
|
ENERGY, SOURCE SIZE, SSD AND BEAM ATTENUATION
|
|
READING ----90 SSD ON AN AP PORTAL. iF YOU MOVE ANTERIORLY WILL THE SSD BECOME GREATER OR LESS |
LESS, BECAUSE YOU ARE MOVING AWAY FOR ISOCENTER (100) |
|
COMPENSATING FILTERS SHOULD BE |
20 CM AWAY FROM THE PT SKIN
|
|
BOLUS BRINGS |
DMAX TO THE PT SKIN SURFACE
|
|
WEDGE FILTERS DISTORT THE ISODOSE DISTRIBUTION BY
|
TILTING THE ISODOSE LINES THROUGH A SPECIFIC ANGLE
|
|
THE ANGLE WHICH THE ISODOSE LINE IS TILTED AT THE CAX OF THE BEAM AND THE 50% ISODOSE CURVE IS CALLED THE
|
WEDGE ANGLE |
|
THE HINGE ANGLE IS |
THE ANGLE BETWEEN TWO FIELDS
|
|
1921R ARE TYPES OF BRACHYTHERAPY |
TEMP SEEDS |
|
PROSTATE SEED IMPLANTS ARE |
125 IODINE AND 198 GOLD
|
|
MOST RADIOSENTSITIVE PHASE IN CELL BIOLOGY
|
M AND LATE G2 PHASE
|
|
MITOSIS CELL CYCLE IN ORDER (PMAT)
|
PROPHASE, METAPHASE, ANAPHASE AND TELAPHASE
|
|
INDIRECT ACTION |
PRODUCES DAMAGE BY CHEMICAL REACTION (WATER)
|
|
INTERPHASE IS THE PERIOD BEFORE GROWTH BEFORE MITOSIS |
3 PHASES: G1,S,G2
|
|
CELL MEMBRANE
|
BARRICADE
|
|
OXYGEN
|
TRUE RADIOSENSITIZER
|
|
LET IS THE |
RATE WHICH ENERGY IS DEPOSITED AS A CHARGED PARTICLE TRAVELS THOUGH MATTER
|
|
ALPHA, NEUTRONS, AND PROTONS
|
HIGH LET, HIGHLY IONIZING
|
|
LET RADIATIONS
|
INCREASE WITH RBE INCREASES
|
|
SUBLETHAL DAMAGE REPAIR
|
SLDR
|
|
EARLY RESPONSE
|
MANIFEXT INJURY WITHIN A FEW MONTHS
|
|
EARLY RESPONSE
|
BONE MARROW, SKIN INTESTINAL LINING AND TESTES
|
|
GOAL OF RADIATION THERAPY
|
MAX THE DOSE TO THE TUMOR WHILE MINIMIZING THE DOSE TO SURROUNDING NORMAL TISSUE
|
|
TIME-DOSE FRACTIONATION IS DETERMINED BY
|
TYPE OF TUMOR AND TOLERANCE OF SURROUNDING TISSUE
|
|
CERROBEND ATTENUATE
|
5% OF THE PRIMARY BEAM OF UNBLOCKED INTENSITY
|
|
DENSITY RATIO OF CERROBEND TO LEAD
|
1.21, WHICH ATTENUATE 5% OF THE PRIMARY BEAM
|
|
HVL IS DEFINED AS
|
THE THICKNESS OF MATERIAL NEEDED TO REDUCE THE INTENSITY TO 1/2 OF ITS ORIGINAL VALUE
|
|
POLYENERGETIC OR HETEROENOUS "MIXED BEAMS"
|
CAUSES BEAM HARDENING
|
|
GEOMETRIC FIELD SIZE IS
|
THE ACTURAL FIELD SIZE AT THE SPECIFIC DIST FROM THE SOURCE LIGHTS FIELD |
|
MONITOR UNIT IS |
BASIC UNIT OF MACHINE OUTPUT LOCATED IN THE COLLIMATORS HEAD |
|
WHEN TWO 45 DEGREE WEDGES ARE USED "WEDGES HEELS" |
THE DOSE UNIFORMITY IS IMPROVED
|
|
1251 AND 103PD ARE TYPES OF BRACHYTHERAPY |
PERMANENT SEEDS |
|
MITOCHONDRIA
|
POWERHOUSE |
|
MOST RADIOSENSITIVE PHASE IN CELL BIOLOGY IS
|
S PHASE
|
|
DIRECT BILOGICAL ACTION |
PRODUCES DAMAGE BY DIRCT IONIZATION
|
|
DIRECT BIOLOGICAL ACTION
|
HIGH LET RADIAITON LIKE PARTICLES OR NEUTRONS
|
|
MESSENGER RIBONUCLEIC ACID MRNA
|
FORM OF RNA THAT MEDIATES THE TRANSFER OF GENETIC INFO
|
|
GOLGI APPARATUS
|
TRANSPORTS ENZYMES
|
|
OXYGEN ENHANCED RATIO OER
|
RADIATION DOSE THAT PRODUCES A BIOLOGICAL RESPONSE IN THE ABSENCE OF OXYGEN
|
|
M AN GAMMA RAYS
|
LOW LET SPARSELY IONIZING
|
|
REB |
DOSE OF RADIAITON COMPARED TO 250 KEV XRAYS |
|
HIGH LET RADIATIONS DO NOT SHOW ANY DOSE RATE EFFECT |
BECAUSE THEIR DENSE AND HAVE A LOT OF MASS |
|
POTENTIALLY LETHAL DAMAGE
|
PLD
|
|
LATE RESPONSE
|
MANIFEST INJURY FOR AT LEAST 3 MONTHS OR LONGER
|
|
LATE RESPNSE
|
LUNG, CNS, KIDNEY, AND LIVER
|
|
THERAPUETIC RATIO
|
NTTD/TLD
|
|
THE 4 R'S
|
REDISTRIBUTION, REPOPULATION, REPAIR, REOXYGENATION
|
|
MOST COMMON MEGAVOLTAGE CERROBEND THICKNESS IS
|
7.5 CM
|
|
DIVERGING BLOCK ARE MADE WITH ALLOW TO
|
COMPENSATE FOR GEOMETRIC DIVERGENCE OF THE BEAM
|
|
TVL "TENTH VALUE LAYER" IS
|
THE THICKNESS OF MATERIAL NEEDED TO REDUCE THE INTENSITY TO 1/10 OF ITS ORIGINAL VALUE
|
|
HETEROGENEOUS IS THE |
MOST GENERATED XRAY BEAM
|
|
RADIATION FIELD SIZE IS DEFINED AT THE |
50% ISODOSE DECREMENT LINE
|
|
MOST COMMON CHARTING ERRORS ARE
|
ADDITION OR TRANSPOSITION
|
|
DNA DAMAGE CHAIN BREAKS |
LOW LET
|
|
CROSS-LINKING BETWEEN STRANDS
|
CAUSED BY UV, XRAYS AND CHEMICALS
|
|
PHYSICAL FIELD SIZE
|
IS THE 50% ISODOSE LINE
|
|
CTV
|
THE AMOUNT TO BE TREATED |
|
PTV
|
THE RECOGNITION OF TX UNCERTANTIES
|
|
VISUALIZATION IS THE
|
DETERMINATION OF THE LOCATION EXTENT OF THE TUMOR
|
|
BREAST LOCATION
|
2ND TO 6TH RIB FROM THE STERNUM TO ANTERIOR AXILLARY LINE
|
|
BRST LYMPHATICS TRANSPECTORAL DRAINS TO THE
|
SUPRACLAVICULAR LYMPH NODE
|
|
BRST LYMPHATICS AXILLARY LYMPH I LOCATION
|
UNDER THE LOWER PORTION AND LATERAL TO THE PECTORALIS MINOR MUSCLE
|
|
BREAST LYMPHATICS AXILLARY LYMPH III LOCATION
|
SUPERIOR TO THE PECTORALIS MINOR MUSCLE
|
|
BREAST HISTOPATHOLOGY MOST COMMON LOCATION
|
UPPER OUTER QUADRANT OF THE LEFT BREAST
|
|
BREAST CA MOST IMPORTANT VARIABLE IS THE
|
HORMONE RECEPTOR STATUS FOR ESTROGEN "ER" OR PROGESTERONE RECEPTOR "PR"
|
|
DUCTAL CARCINOMA IN SITU (DCIS) DOES NOT
|
MET
|
|
BREAST TX PORTALS FOR THE INFERIOR BORDER ARE
|
1.5 CM BELOW INFRAMAMMARY FOLD
|
|
HEAD AND NECK HISTOPATHOLOGY ARE MOSTLY |
80% ARE SQUAMOUS CELL CARCINOMAS "SCC"
|
|
ADENOCARCINOMA ARISE FROM THE MINOR SALIVARY GLAND |
TO THE MUOSAL LINING OF THE AERODIESTIVE TRACT FROM THE MAJOR SALIVARY GLAND
|
|
LYMPHOEPITHELIOMA OCCURS IN THE
|
TONSIL AND BASE OF TONGUE AND ITS OF SSC TYPE
|
|
HEAD AND NECK HISTOPATHOLOGY FRO LARYNX CA |
MOST SCCS ARE OF TRUE VOCAL CORD
|
|
HEAD AND NECK LOCATION FOR ORAL CAVITY
|
ANT 2/3 OF THE TONGUE
|
|
HEAD AND NECK LYMPHATICS DRAINAGE FOR LARYNX |
JUGULODIGASTRIC, MIDJUGULAR AND LOWER JUGULAR NODES
|
|
HEAD AND NECK LYMPHATICS DRAINAGE FOR LARYNX
|
GLOTTIS, SUPRAGLOTTIS AND SUBLOTTIS
|
|
GLOTTIS CONSITS OF THE
|
RIGHT AND LEFT TRUE VOCAL CORDS
|
|
DNA DAMAGE DOUBLE CHAIN BREAKS
|
HIGH LET
|
|
CROSS-LINKING BETWEEN TWO IRRADIATED MOLECULES
|
BASE DAMAGE CAUSED BY UV LIGHT
|
|
CAX DOSE VALUES ARE NORMALIZED OR DIVIDED BY |
THE MAX VALUE TO CALC DEPTH DOSE
|
|
GTV
|
EXTENT ADN LOCATION OF MALIGNANT GROWTH
|
|
PTV INCLUDES THE |
CTV PLUS MARGIN |
|
LOCALIZATION OR SIMULATION IS THE
|
DETERMINATION RADIOGRAPHICALLY OF THE FIELD BORDERS
|
|
BREAST LYMPHATICS MAJOR ROUTE OF NODA DRAINAGE
|
AXILLARY
|
|
BREAST LYMPHATICS
|
AXILLARY, INTERNAL MAMMARY AND TRANSPECTORAL
|
|
BREAST LYMPHATICS THE 2 TYPES
|
DEEP AND SUPERFICIAL
|
|
BREAST LYMPHATICS AXILLARY LYMPH II LOCATION
|
DIRECTLY UNDER THE PECTORALIS MINOR MUSCLE
|
|
BREAST HISTOPATHOLOGY MOST COMMON MALIGNANT TYPE
|
INFILTRATING DUCTAL
|
|
BREAST HISTOPATHOLOGY MOST COMMON NON-INVASIVE TYPE
|
NONIVASSIVE DUCTAL CARCINOMA "DCIS"
|
|
BRST CA: SYSTEMIC CHEMO IS USED FOR PT WITH
|
METS WHOSE TUMOR HORMONE RECEPTORS ARE NEGATIVE
|
|
DCIS IS
|
RADIOSENSITIVE
|
|
A 10% TO 15% ANGLE FOR A SUPRACLAV PORTAL PREVENTS
|
EXPOSURE TO THE SPINAL CORD AND ESOPHAGUS |
|
HEAD AND NECK HISTOPATHOLOGY ARISE FROM THE
|
EPITHELIAL LINING OF THE AERODIGESTIVE TRACT |
|
SQUAMOUS CELL CA (SCC) ACCOUNT FOR
|
90% OF ORAL CAVITY CA |
|
H&N HISTOPATH FOR LARYNX CA
|
95% ARE SCC
|
|
H&N LYMPH DRAINAGE FOR OROPHARANX
|
SUPERIOR JUGULAR, JUGULODIGASTRIC, MIDJUGULAR AND LOWER JUGULAR NODES
|
|
H&N LYMPH DRAINAGE FOR ORAL CAVITY
|
JUGULODIGASTRIC, MIDJUGULAR, LOWER JUGULAR AND SUBMANDIBULAR NODES
|
|
H&N LYMPH DRAINAGE FOR HYPOPHARYNX
|
JUGULODIGASTRIC, MIDJUGULAR AND LOWER JUGULAR NODES |
|
H&N LARYNX TX PORTS
|
OPPOSED LATS AND WEDGES ANT
|
|
FLETCHER SUIT IS MOSTLY USED FOR
|
BRACYTHERAPY IMPLANTS FOR A CARCINOMA OF THE CERVIX
|
|
MEDULLOBLASTOMAS ARE THE
|
MOST COMMON PRIMARY INTRACRANIAL TUMOR OF THE POSTERIOR FOSSA IN CHILDREEN
|
|
RHABDOMYOSARCOMA IS THE MOST COMMON
|
SOFT TISSUE SARCOMA (STS) IN CHILDREN
|
|
OPTIC NERVE
|
__COND CRANIAL NERVE
|
|
THE COLLIMATOR OF A RADIOTHERAPY SIMULATOR
|
SIMULATES PLANNED FIELD, SHOW LIGHT TO FIELD CONGRUENCE AND MEASURES TX FIELD
|
|
MEIOSIS
|
REDUCES THE NUMBER OF CHROMOSOMES BY HALF
|
|
ELECTRON GUN IS THE
|
SOURCE OF E- IN A LINAC
|
|
EDR (EXCESSIVE DOSE RATE) IS THE
|
__ULT LIGHT INDICATORS FOR A (LINAC) THAT INDICATES TOO MANY MONITOR UNITS COUNTED DURING A 0.01 MINUTE INTERVAL
|
|
KLYSTRON IS THE
|
SOURCE OF MICROWAVE POWER TO ACCERLERATE E- IN A LINAC
|
|
STRUCTURE WITH THE HIGHEST RADIOSENSITIVITY IS THE
|
LENS OF THE EYE
|
|
MYCOSIS FUNGOIDES BY E- BEAM THERAPY INVOLVES
|
ENTIRE SKIN SURFACE
|
|
NORMAL TX FOR CA OF THE BREAST PORTALS ARE |
TANGENTIAL OPPOSED FIELDS
|
|
IRRADIAITON OF THE PARA-AORTIC AREA
|
MOST COMMONLY A SEMINOMA
|
|
LYMPHOCYTIC DEPLETED IS AN INDICATOR FOR A
|
HODGKINS DISEASE HAS THE POOREST LONG TERM PROGNOSIS
|
|
OLIGODENDROGLIOMA IS A
|
RARE SLOW GROWING TUMOR OF THE BRAIN
|
|
MOST COMMON COMPLAINT PRIOR TO DIAGNOSIS OF A SOFT TISSUE SARCOMA
|
A PAINLESS LUMP
|
|
LYMPHATIC SPREAD OF AN ANAL LESION
|
OBTURATOR NODES, ILIAC NODES AND INGUINAL NODES
|
|
THE AGE AT WHICH WHILM'S TUMOR OCCURS
|
1-10 YRS OF AGE
|
|
MALIGNANT TESTICULAR TUMORS ORIGINATE
|
GERM CELLS
|
|
TRANSITIONAL CELL CARCINOMAS ARE
|
____ SYSTEM TUMORS FROM THE MUCOUS MEMBRANE LINING
|
|
SEMINOMA IS A TYPE OF TUMOR OF THE
|
TESTIS
|
|
MOST COMMON TYPE OF LUNG CA
|
___SQUAMOUS CELL CA ???
|
|
60% OF MET BRAIN LESIONS ARISE FROM
|
PRIMARY LUNG LESION
|
|
___ ORIGIN OF CA OF THE PANCREAS
|
___ THE PANCREAS???
|
|
SARCOMAS TEND TO METASTASIZE
|
THE BLOOD STREAM
|
|
TUMORS OF THE MUSCLES ARE NOT
|
RADIOSENSITIVE
|
|
TUMORS ARISING FROM BLOOD ELEMENTS, TUMORS OF THE EMBRYONAL CELL ORIGIN AND NORMAL BONE MARROW ARE
|
RADIOSENSITIVE
|
|
WILM'S TUMOR IS A
|
NEPHROPLASTOMA
|
|
MOST RADIOSENTIVE LYMPHOMA IS
|
HODGKINS DISEASE
|
|
TX VOLUME FOR MEDULLOBLASTOMAS
|
___ SPINAL CORD???
BRAIN??? |
|
A BEAM SPLITTER IS USED TO
|
TRIM THE SUPERIOR EDGE OF THE TANGENTAL TX PORTAL
|
|
1 GY
|
100 CGY
|
|
MULTIPLE MYELOMA IS A NONOSSEOUS
|
MALIGNANT MARROW TUMOR
|
|
SUPRAGLOTTIS CONSIST OF THE FALSE VOCAL CORDS AND THE
|
EPIGLOTTIS, RIGHT AND LEFT ARYEEPIGLOTTIC FOLD, ARYTENOIDS
|
|
H&N POSTERIOR BORDERS |
ANT MARGIN OF THE VERTEBRAL BODIES
|
|
SUBGLOTTIS EXTENDS FROM THE
|
GLOTTIS TO THE LOWER MARGIN OF THE CRICORD CARTILAGE
|
|
H&N SUPERIOR BORDERS
|
TOP OF THE THYROID CARTILAGE
|
|
STOMACH LYPHATIC FLOW
|
DRAINS TO THE CELIAC AXIS NODES
|
|
H&N INFERIOR BORDERS
|
BELOW THE CRICOID CARTILAGE
|
|
100KEV XRAYS IS THE BEAM THAT PRODUCES
|
MAX DOSE AT SKIN SURFACE
|
|
BEAM PRODUCES MAX DOSE AT ABOUT 1CM DEPTH
|
4 MEV XRAY
|
|
DEPTH OF MAX IONIZATION IS MOST DEPENDENT UPON
|
XRAY BEAM ENERGY
|
|
SIGNIFICANTLY INFLUENCE %DD
|
SSD, FIELD SIZE, BEAM ENERGY AND DEPTH
|
|
SIGNIFICANTLY INFLUENCE BACKSCATTER FACTORS
|
FIELD SIZE, ENERGY
|
|
SIGNIFICANTLY INFLUENCE TAR
|
FIELD SIZE, ENERGY, DEPTH
|
|
SSD AND DEPTH
|
DOES NOT SIGNIFICANTLY INFLUENCE BACKSCATTER FACTORS
|
|
SSD
|
DOES NOT SINIFICANTLY INFLUENCE TAR
|
|
TRIMMERS
|
REDUCE RADIATION FIELD PENUMBRA
|
|
OPTICAL LOCALIZER LIGHT AND THE RADIATION FIELD
|
2.0 MM
|
|
WHAT IS THE EQUIVILANT AREA OF THIS FIELD 8CM X 15CM |
10.4 OR 108.8- (SQ 10.4)
|
|
EQUATION FOR COMPUTING ACCUMULATED DOSE FOR RADIAITON WORKERS
|
5 (N-18)
|
|
1/10 IS THE WORKERS
|
INDIVIDUALS OCCASIONALLY EXPOSED FRACTION
|
|
OUTPUT RATE FOR A TX UNIT
|
R/MIN
|
|
FILM BADGE IS BACKED BY WHAT KIND OF FOIL TO ABSORB BACK-SCATTERED RADIATION |
LEAD
|
|
0.1% OF THE USEFUL BEAM AT 1 METER IS THE |
LEAKAGE LIMITS OF A RADIAITON THERAPY SOURCE HOUSING WITH THE BEAM ON
|
|
150-500 KV IS THE
|
OPERATING POTENTIALS FOR ORTHOVOLTAGE THERAPY
|
|
10 MR/HR AT 1 METER IS THE
|
LEAKAGE LIMITS OF RADIATION THERAPY SOURCE HOUSING WITH THE BEAM OFF
|
|
THE 2 MAIN RADIAITON PROTECTION LAWS WHEN LOADING OR UNLOADING A PATIENT WITH BRACYTHERAPY SOURCES
|
TIME AND DISTANCE, PERSONAL SHIELDING IS N/A
|
|
ABSORBED DOSE X QUALITY FACTOR EQUALS THE |
DOSE EQUIVILENT
|
|
ABSORBED DOSE X QUALITY FACTOR EQUALS THE
|
DOSE EQUIVALENT
|
|
30 REM/YR IS THE
|
MPD LIMITS OF EXPOSURE TO THE FOREARM
|
|
QUALITY FACTOR FOR BETA, GAMMA, AND XRAYS
|
1
|
|
THE DEGREE OF USE OF AN X OR GAMMA SOURCE IS
|
WORKLOAD
|
|
5 REM IS THE
|
MAX PERMISSIBLE PROSPECTIVE DOSE IN 1 YR FOR WHOLE BODY IRRADIATION FROM ALL OCCUPATIONAL SOURCES SHOULD NOT EXCEED
|
|
THE LARGEST QF IS
|
ALPHA PARTICLES
|
|
MEASURES CUMULATIVE RADIATION EXPOSURE TO PERSONAL
|
FILM BADGE, TLD, -POCKET DOSIMETER
|
|
LEAST AMOUNT OF SKIN SPARING
|
SUPERFICIAL TX UNIT
|
|
GREATEST AMOUNT OF SKIN SPARING
|
LINEAR ACCELERATOR
|
|
ON A LINEAR ACCELERATOR WHAT MAY BE USED TO TERNIMATE ALL POWER
|
TX ROOM PANIC BUTTON, EMERGENCY OFF BUTTON ON THE CONTROL CONSOLE
|
|
IF THE TX COUCH WITH THE PATIENT ON IT WILL NOT STOP__- WHAT SHOULD YOU DO TO STOP THE COUCH
|
THE MAIN CIRCUIT BREAKER
|
|
A TYPE OF MECHANICAL OR OPTICAL PT ALIGNMENT DEVICE
|
SPIRIT LEVEL
|
|
WHILE TREATING A PT USING A ROTATIONAL TECHNIQUE THE GANTRY ROTATES PAST THE END POINT
|
LIMIT SWITCH MALFUNCTION
|
|
COLLIMATOR ALIGNMENT AND MIRROR ANGULATION ARE
|
SOURCES OF LIGHT MISALIGNMENT
|
|
HEMOPOIETIC SYNDROME 200-800 RADS
|
ACUTE RADIATION SYNDROME
|
|
GREATEST PROBABILITY OF INTERACTING WITH MATTER
|
ALPHA PARTICLES
|
|
10% IS THE
|
ACCEPTABLE VALUE FOR A HIGH DOSE (HOT SPOT) RE___ WEDGE PAIR TECHIQUES
|
|
MOST COMMON PRIMARY SITE FOR BONE SARCOMA
|
METAPHYSEAL
|
|
PROGNOSTIC FACTORS INCLUDE |
AGE, GENDER, AND LOCATION
|
|
CLL IS A LEUKEMIA THAT HAS NOT
|
HD PREVIOUS RADIATION EXPOSURE
|
|
THE GLOTTIS IS
|
A TRUE VOCAL CORD
|
|
A T1 LARYNGEAL TUMOR IS CONFINED TO THE
|
TRUE VOCAL CORDS
|
|
ISO CURVESRS |
DEPTH DOSE
|
|
ORTHOVOLTAGE TX UNIT
|
150-500 KVP AT 50-70 CM SSD
|
|
BRACHYTHERAPY
|
INTERSTITIAL OR INTERCAVITARY
|
|
SUPERFICIAL TX UNIT
|
50-20 AT 15-20 CM SSD
|
|
MEGAVOLTAGE TX UNIT |
1 MV OR GREATER AT 80-100 CM SSD
|
|
ISOCENTER IS THE
|
POINT AROUND WHICH THE SOURCE OF THE BEAM ROTATES
|
|
BACKSCATTER FACTOR IS
|
LARGER WITH LOWER ENERGY BEAM
|
|
A FLATTENING FILTER IN A LINAC |
REDUCED THE FORWARD PEAK DOSE IN THE CENTER OF THE UNFILTER BEAM
|
|
OPTIMAL TX PLAN IS ONE THAT |
RESULTS IN THE UNIFORM DOSE TO THE TUMOR DOSE IN ADJACENT TISSUES |
|
PENUMBRA IS THE
|
REGION NEAR THE FIELD EDGE WHERE DOSE FALLS RAPIDLY
|
|
ION CHAMBER IS USED TO
|
MEASURE OUTPUT
|
|
GAP CALC; FS1 IS 12 X 12, FS2 8 X8 AT A DEPTH OF 10CM TO BE TX AT 80 SSD |
1.25CM
|
|
THE BASIC PROCESS RESPONSIBLE FOR RADIATION DETECTION OPERATION IS
|
IONIZATION |
|
IF YOUR HAVE A TX OF 1.8 GY AND THE TRAY WAS LEFT IN "0.95 T-FACTOR" WHAT IS THE NEW CY |
1.71, 1.8X0.95=1.71 "THE ANSWER SHOULD BE LESS"
|
|
THE MOST SUITABLE MATERIAL FOR REDUCING ELECTRON CONTAMINATION
|
LEAD AND TUNGSTEN
|
|
TO PRODUCE THE LEAST AMOUNT OF ELECTRON CONTAMINATION THE TRAY OR ANY DEVICE SHOULD |
BE 15 CM AWAY FROM THE SKIN SURFACE |
|
TISSUE AIR RATIO VARIES WITH
|
FIELD SIZE, ENERGY, AND DEPTH
|
|
GREATEST BSF IN SOFT TISSUE IS WITH
|
2MM AT HVL XRAYS
|
|
A SINGLE POSTERIOR TX PORTAL IS TREATED AT 130 CM CONPAIRED TO 80CM SSD BECAUSE
|
EXIT DOSE WILL BE GREATER DUE TO BEAM HARDENING
|
|
THE FACTOR USED TO DETERMINE THE AMOUNT OF INCREASED IN %DD AS THE SSD IS
|
MAYNEORD'S F FACTOR
|
|
PDD/%DD INCREASED WITH INCREASING SSD, WHY
|
%DD IS DIRECTLY PORPORTIONAL WITH SSD
|
|
THE SHAPE OF THE ISODOSE CURVE IS DEPENDANT ON
|
FILD SIZE, FLATTENING FILTER AND SSD
|
|
TISSUE INHOMGENEITIES THAT ALTER DOSE DISTRIBUTION
|
AIR CAVITIES, LUNGS, FAT AND BONE
|
|
WEDGE FILTER CORRECT FOR
|
SKIN SPARRING EFFECT
|
|
PARAMETERS NECESSARY TO DETERMINE BLOCK FABRICATION AND TX ACCESSORIES ARE
|
FIELD SIZE AND SHAPE, TARGET FIM DISTANCE "TFD" SSD AND HALF VALUE THICKNESS OF THE BLOCK
|
|
SIZE OF THE LYMPH NODES AND HISTOLOGY ARE
|
MANAGEMENT FACTORS OF NECK CARCINOOMAS WITH POSITIVE LYMPH NODES
|
|
A TX PLAN IS NORMALIZED TO THE 175 CGY ISODOSE LINE WHAT % WILL THE 200 CGY ISODOSE LINE GET
|
114% BECAUDE175=100% LINE
WE ARE INCREASING 175 TO 200` |
|
SAFITTAL PLAN IS FROM
|
RIGHT TO LEFT / LEFT TO RIGHT
|
|
IF PT HAS TUMOR 10CM FROM THE ANT SURFACE AND IS SET UP USING AN ISOCENTRIC TECHNIQUE 80CM SAD, HOW FAR IS THE SOURCE FROM THE TUMOR
|
80 CM, BECAUSE IT WAS SET UP AT SAD
|
|
CALC THE MU'S REQ TO DELIVER 100 CGY TO A DEPTH OF 6 CM FOR A 6MV BEAM. THE TAR IS 0.888 AND THE CGY/MU IS 1.02
|
___ MU???
|
|
IF A PT HAS A TUMOR 10 CM FROM THE ANT SURFACE AND IS SET UP USING AN ISOCENTRIC TECHDNIQUE 80CM SSD, HOW FAR IS THE SOURCE FROM THE TUMOR
|
90 CM, BECAUSE IT WAS SET UP AT SSD
|
|
A 2/3 SHIFT`
|
CAN MAKE A FLAT SURFACE ISODOSE DISTRIBUTION APPLY TO ANY ANGLED SURFACE
|
|
THE HIGH ENERGY LINACS ELECTRON STREAM IS BENT TO DIRECT THE STREAM TO THE TARGET VIA
|
BENDING MAGNENT "FOCUSING COILS"
|
|
WHAT FININSHING ANGLE RESULTS FROM AN ARC SETUP WITH A STARTING ANGLE OF 270 DEGREES WITH CLOCKWISE ROTATION, THE MU/DEGREE= 1.25 AND THE MU SETTING =208
|
104 DEGREES
|
|
THE SPREADING OF ELECTRON BEAMS FROM A LINAC
|
SCATTERING FOIL
|
|
WHAT IS THE HINGE ANGLE FOR A 30 DEGREE WEDGE
|
120* DEGREES, FORMULA "180-30-30=120*
|
|
SUPERFICIAL HAS THE
|
LEAST AMOUNT OF SKIN SPARING
|
|
TILTING OF AN ISODOSE CURVE IS BEST ACCOMPLISHED BY A
|
WEDGE FILTER
|
|
THE LOWEST MV XRAY ENERGY WILL HAVE THE
|
LEAST BACKSCATTER
|
|
THE CONSTRUCTION OF CERROBEND "SHIELDING BLOCKS"THESE PARAMETERS MUSTE BE CONSIDERED
|
BEAM QUALITY, SOURCE TO BLOCK DISTANCE AN SOURCE FIELD DISTANDCE "SFD"
|
|
THROACIC CAVITY CRITICAL STRUCTURES TO CONSIDER THEIR MAX TOLERABLE DOSE
|
LUNG, HEART AND SPINAL CORD
|
|
ABDOMINAL TX CRITICAL STRUCTURES TO CONSIDER THEIR MAX TOLERABLE DOSE
|
SML BOWEL, BLADDER, RECTUM & AND KIDNEYS
|
|
PELVIX TX CRITICAL STRUCTURES TO CONSIDER THEIR MAX TOLERABLE DOSE
|
SML BOWEL, BLADDER AND RECTUM
|
|
THE DEPTH OF MAX IONIZING RADIATION (DMAX) IS MOST DEPENDANT ON
|
BEAM ENERGY
|
|
TISSUE COMPENSATING FILTERS
|
HAE ADVANTAGES OVER THE USE OF BOLUS IN HGH ENERGY RADIATION THERAPY
|
|
TX OF THE RECTUM REQUIRES THE PT TO BE IN THE
|
PRONE POSITION, 3 FIELD WEDGES
|
|
BONE METS IS NOT
|
AN INDICATION FOR THE USE OF E-
|
|
EARLY STAGE LARYNX CA REQ THE TX
|
OF PRIMARY TUMOR ONLY
|
|
WHEN TREATING THE NASOPHARYNX THE STRUCTURES THAT MUST BE CONSIDERED ARE
|
OCCIPITAL LOBE OF BRAIN, BRAIN STEM, OPTIC CHIASM, AND PAROTID
|
|
A WBC BELOW 2000 WILL
|
REQ A STOPPAGE OF HODGKINS TX
|
|
THE SUPERIOR AND INFERIOR BORDERS OF THE MANTLE PORTAL FIELD
|
MASTOID TIP AND XIPHOID PROCESS
|
|
AML IS A TYPE OF LEUKEMIA SEEN
|
SAME FREQ IN ALL DECADES OF LIFE
|
|
TRUE VOCAL CORDS ARE LOCATED WITHIN A CATILAGINOUS STRUCTURE IS THE
|
LARYNX
|
|
SHADOW TRAY HOLDS
|
SHIELDING BLOCKS
|
|
OUTER PORTION OF THE EYE
|
CORNEA
|
|
DIVERGENT BLOCKS PERMIT THE USE OF THE
|
LONGEST SOURCE TO SURFACE DISTANCE
|
|
COMPENSATING WEDGES PROVIDE
|
SKIN SPARING EFFECT FOR SLOPING SKIN SURFACES
|
|
NORMAL CELL TYPES FOUND IN LYMPHOCYTES
|
B & T CELLS
|
|
IF A PT FALLS
|
GET A DOCTOR, HELP THE PT UP AND FILL OUT AN INCIDENT REPORT
|
|
STRONTIUM-89 IS USED TO
|
RELIEF OF BONE MET PAIN
|
|
BON PAIN RELIEF BY STRONTIUM-89 IS A ACCOMPLISHED TY THE
|
UPTAKE OF A BETA-EMITTING ISOTOPE
|
|
SPLENIC FLEXURE IS THE JUNCTION OF
|
TRANSVERSE AND DESCENDING COLON
|
|
FAILURE OF THE MAGNETRON, BEAM TRANSPORT SYSTEM AND ELECTRON GUN WILL ALTER
|
ENERGY OUTPUT OF A LINAC
|
|
2.5 CM SUP & 2.5 CM ANT TO THE EAM
|
LOCATION OF THE PITUATTARY FOSSA
|
|
MOST COMMON SITE OF MALIGNANCE IN H&N
|
LARYNX
|
|
PRESCRIBED DOSE FOR HISTOLOGIC TUMOR IS BASED ON THE EVALUATION OF
|
CRYOGENIC FACTORS, STAGE OF DISEASE, AND PATHOLOGIC GRADE
|
|
RADIOSENSITIVITY IF TISSUE WILL EFFECT
|
ISODOSE CURVE SHAPE
|
|
THE CERVIX IS
|
A THICK WALLED MUSCULAR ORGAN AT THE LOWER CONSTRICTED PORTION
|
|
AT BEAM ENERGIES ABOVE 8 MEV THE BSF BECOMES
|
NEGLIGIBLE
|
|
NEGATIVE SHIELDING BLOCKS
|
LUNG
|
|
POSITIVE SHIELDING BLOCKS
|
ABDOMEN, H&N, SHOULDERS
|
|
HIGHEST % OF ESOPHAGEAL CARCINOMAS ARE IN THE
|
TERMINAL ESOPHAGUS
|
|
MAX ENERGY AT 180* FROM A SCATTERING OBJECT
|
255 KEV
|
|
THROMBOCYTES
|
HELP DESTROY INVADING ORGANISMS
|
|
NORMAL RED BLOOD CELL COUNT FOR AN ADULT
|
5,000,000 PER CC "5 MILLION"
|
|
EQUIVALENT SQUARES
|
EFFECTS USING SHIELDING BLOCKS
|
|
OATS CELL CARCINOMA
|
LUNG CA THAT IS SYSTEMIC
|
|
CACHEXIA IS CHARACTERIZED BY
|
ANOREXIA, SATIETY, ANEMIA, AND WEIGHT LOSS
|
|
SSD, SSD AND SOURCE SIZE EFFECTS THE
|
SHAPE OF THE ISODOSE CURVE
|
|
HODGKINS DISEASE WITH INVOLVEMENT OF THE SPLEEN AND MEDIASTINAL NODES
|
STAGE 3
|
|
STAGE OF CERVIX WITH EXTENSION OF LOWER 1/3 WITH NO INVOLVEMENT OF THE PELVIC WALL
|
STAGE 3A
|
|
HEART CAVITY LOCATION
|
MEDIASTINUM
|
|
LEVEL OF AORTIC BIFURCATION
|
T4/T5
|
|
BEST WAY TO TREAT A BLADDER IS 3 FIELD WHY
|
MINIMUM DOSE TO THE RECTUM, NODES WILL BE INCLUDED AND URETHRAS WILL GET A HIGH DOSE
|
|
LOCATION OF THE KIDNEY
|
11TH RIB TO L3
|
|
WHAT GOES FROM C2 TO THE CARINA
|
TRACHEA
|
|
BASAL AND SQUAMOUS CELL CA ARE
|
RADIOSENSITIVE TO RADIATION
|
|
BLOOD, URINE AND SALIVA ARE ALL RADIOACTIVE AFTER USAGE OF
|
STRONTIUM-89, A PURE BETA EMITTER AND TRANSPORTED IN A WOODEN BOX
|
|
OVOIDS USED TO TREAT
|
3000 CGY DOSE, AP/PA PROTALS, BLOCK KIDNEYS AND LIVER W__ 1-2 HVLS
|
|
ESOPHAGUS TX TO MID 1/3 TO 6500 CGY, WHAT IS THE BEST TECHNIQUE
|
AP & 2 POSTERIOR OBLIQUES
|
|
BASAL AND SQUAMOUS CELL CA ARE
|
RADIOSENSITIVE TO RADIATION
|
|
DIVERGENT BLOCKS REDUCE
|
COMPENSATE FOR THE GEOMETRIC DIVERGENCE OF THE BEAM
|
|
WHAT MOVES DURING A PHOTON TO AN E- TX THAT BLOCKS THE FIELD LIGHT
|
SCATTERING FOIL
|
|
STOMACH LOCATED IN THE LUQ
|
BEGINS AT THE GE JUNCTION, ENDS AT THE PYLORUS JOINING THE DUODENUM IN THE
|
|
IF THE TX TABLE STARTS TO GO UP DURING A TX AND THE EMERGENCY OFF BUTTON DOESNT WORK WHAT DO YOU DO
|
MAIN CIRCUIT BREAKER
|
|
IF THE DOOR INTERLOCK DOSE NOT WORK WHAT DO YOU DO
|
NOTIFY THE PHYSICIST OR RSO, GET THE PATIENT OUT OF THE ROOM
|
|
MELANOMAS ARE
|
THE MOST RADIORESISTANT
|
|
SUB CRANIAL BLOCK IS USED FOR
|
BRAIN BLOCK USED DTO TREAT THE ENTIRE CRANIAL VAULT
|
|
WRONG WEDGE IN DURING TX, WHAT DO YOU DO
|
STOP TX AND NOTIFY DOSIMETRIST
|
|
IF THE MACHINE FAILS DURING TX HOW DO YOU KNOW HOW MUCH THE PT RECEIVED
|
THE MECHANICAL COUNTER IN THE TX CONSOLE
|
|
WHAT IS THE HALF BEAM BLOCK USED FOR
|
NON DIVERGENT EDGES FOR FIELD ABUTMENT
|
|
MOST RADIOSENSITIVE TISSUE GROUP
|
ALIMENTARY TRACT TISSUE (IE SMALL BOWELL)
|
|
VULVA NODES DRAIN TO
|
INGUINAL NODES, BLOOD SERUM FROM THE VULVA
|
|
HYPOXIC MEANS
|
DECREASE IN OXYGEN
|
|
DOMES OF THE DIAPHRAGM ARE TX FOR WHOLE ABD TO ENSURE
|
THAT THE CORRECT AMOUNT OF TX PORTAL IS INCLUDED
|
|
WHEN A PT IS TX FOR SVC, THE EARLIER TX MAY REQUIRE
|
NEW MEASURMENTS AFTER A FEW DAYS
|
|
THE PT SUPINE MEASURES 22 DEPTH AT 100 CM SAD, THE WIDTH SEPARATION IS 36 CM. IF THE ISOCENTER IS SHIFTED 3 CM ANT, WHAT IS THE NEW PA SSD
|
22/2= 11 WHICH IS 89 SSD
89-3 "ANT SHIFT" = 86 PA SSD |
|
WHICH GI MUCOSA HAS THE GREATEST RADIOSENSITIVITY
|
RECTUM
|
|
IF 1 CM IS ADDED TO THE SUP/TOP OF THE PORTAL, WHAT HAPPENS TO THE ORIGINAL ISOCENTER
|
NOTHING
|
|
WHERE CAN A PERSON FIND INFO ON WHAT TO DO IF THEY THINK THEY EXPOSED TO PROCESSING FILM AGENT CHEMICAL
|
MATERIAL SAFETY DATA SHEET "MSDS" CHEMICAL LABEL AND BROCHURE
|
|
IF THE PT IS PRONE AN A ANTERIORLY ISO SHIFT IS NEEDED, WHAT DO YOU DO
|
-PT PRONE "AP" FIELD SIZE DECREASES WITH ANT SHIFT
-PT PRONE "AP" FIELD SIZE INCREASES WITH POST SHIFT |
|
WHAT ARE PROBLEMS WITH MAKING BLOCKS
|
INGESTING ALLOYS, INHALING ALLOYS AND BURNS
|
|
WHAT SALIVARY GLAND IS LOCATED ANTERIOR AND INFERIOR TO THE EAR
|
PAROTIC GLAND, THE LARGEST GLAND
|
|
WHERE IS WALDERYERS RING
|
BRAIN, OPPOSED LAT TX PORTALS
|
|
WHEN TREATING A NASOPHARYNX THE LATERAL HAS A 5=10* POST ANGLE TO
|
AVOID THE EYES
|
|
WHEN TREATING THE PROSTATE, WHY IS THE BLADDER FULL
|
TO MOVE THE SML INTESTINES OUT OF THE WAY
|
|
THE CERVICAL OS IS THE
|
LOWER BORDER OF CERVIX
|
|
WHY USE A MIDLINE BLOCK FOR TX OF THE CERVIX
|
BOOST PARAMETRIAL NODES, BLOCK IMPLANT AREA, BLOCK THE BLADDER AND RECTUM
|
|
SYMTOMS OF PANCOAST TUMORS ARE
|
SHOULDER PAIN, SUPERIOR PULMONARY SULCUS IN THE APEX OF THE LUNG, THE TUMOR HAS A MASS GROWING AT THE THORACIC INLET
|
|
MOST MARROW IS IRRADIATED IN AN ADULT
|
PELVIC GIRDLE AND EXTREMITY
|
|
WHAT WOULD DEPRESS HEMOPOIETIC SYSTEM MOST
|
HOCKEY STICK AND INVERTED Y TX
|
|
BSF
|
TAR @DMAX
|
|
MOST COMMON INDIRECT ACTION
|
FREE RADICALS ARE FORMED
|
|
STERILE TECHNIQUE ARE USED WHEN
|
PLACING INSTRUMENTS IN BODY CAVITIES
|
|
ASEPTIC TECHNIQUES IS USED
|
WHEN SKIN IS PUNCTURED OR PIERCED
|
|
IONIZATION OF AIR
|
EXPOSURE AND TAR
|
|
ROENTGEN TO RAD CONVERSION FACTOR
|
F-FACTOR OR F MED
|
|
THE MOST RADIOSENSITIVE MAJOR COMPONENT OF BONE
|
OSTEOBLASTS
|
|
DOSE RATE OUTPUT IS CHECKED
|
ANNUAL
|
|
ORDER OF OCCURRENCE
|
1ST- EPILATION
2ND-DRY DESQUAMATION 3RD- MOIST DESQUAMATION |
|
RESCUE BREATHES
|
2 & 1 MAN= 15;2, 100 COMPRESSION PER 1 MIN
|
|
IV IS INFILTRATED HOW DO YOU KNOW
|
INJECTION SITE BECOMES COOL AND RED
|
|
MOST COMMON THYROID DIAGNOSIS
|
PAPILLARY
|
|
KELOIDS
|
ARE CAUSED BY BURNS FROM 15-18 GY IN 3 FRACTIONS
|
|
WHICH IS TRUE OF OSTEOSARCOMAS
|
TRAUMA IS A PROVEN ETIOLOGY AND HISTOLOGIC GRADE IS USED FOR STAGING
|
|
WHEN DO YOU TX A WHOLE BRAIN PROPHALACTICLY
|
SMALL CELL
|
|
FOR THE PROSTATE METS SPREAD TO THE LIVER BY WAY OF THE
|
PORTAL VEIN
|
|
BEST WAY TO KEEP PORTAL MARKINGS IS TO
|
__ THE MARKER TO THE PT TO TOUCH UP
|
|
PDD/%DD DOES NOT DEPEND ON
|
FILTRATION
|
|
THE LARYNX LIES
|
__ TO C6
|
|
THE BREAST BOARD IS USED TO
|
DECREASE SLOPE OF THE STERNUM AND GET BETTER REPRODUCIBILITY
|
|
AP/PA FIELD WEIGHTED 3:1 WITH DOSE OF 200
|
AP 150 TO PA 50, 200/4 =50 X 3 =150
|
|
MOST RADIOSENSITIVE PART OF NORMAL CELL
|
CHROMOSOME
|
|
AFTER A SINGLE INJECTION OF A RADIOACTIVE MATERIAL WHAT DO YOU DO WITH THE SYRINGE
|
PLACE IN BIOHAZARD CONTAINER, SEND IT TO TE MANUFACTURE FOR DISPOSAL
|
|
ISOCENTER IS
|
ROTATION OF GANTRY AND HORIZONTAL AXIS OF THE TABLE
|
|
MOST COMMON SYMPTOM OF A SALIVARY GLAND CA
|
FACIAL PALSY
|
|
MANIFEST PERIOD
|
THE TIME AFTER AN ACUTE EXPOSURE TO RADIATION
|
|
THE MOST SENSITIVE CELL OF THE BODY TO RADIATION
|
SPERMATAGONIA
|
|
PRODROMAL SYNDROME
|
EARLY RADIATION SICKNESS, NAUSEA AND VOMITING AT DOSES BETWEEN 1 TO 2 GRAY
|
|
DURING IRRADIATION OF THE ESOPAGUS THE SENSITIVE INTRATHORACIC STRUCTURES ARE
|
SPINAL CORD, HEART AND LUNG
|
|
BOLUS IS USED IN HIGH ENERGY PHOTON TX MAINLY FOR
|
INCREASED SKIN DOSE, CORRECT FOR TISSUE INHOMOGENEITY
|
|
MOST LIKELY CAUSE OF INTERACTIONS IN BONE @ ORTHOVOLTAGE RANGE
|
PHOTOELECTRIC OR CHARACTERISTIC
|
|
TUMOR CAN BE DESTOYED BUT NORMAL TISSUE SUFFERS SEVERE COMPLICATION
|
RADIORESISTANT TUMOR
|
|
RADIATION DAMAGE TO READIORESISTANT ORGANS
|
INDIRECTLY VIA VASCULATURE DAMAGE
|
|
ADVERSE EFFECT ON WBC PRODUCTION IS MOST LIKELY AFTER EXPOSURE TO THE
|
SKELETAL SYSTEM
|
|
A DECREASE IN LYMPHOCYTE COUNT AFTER
|
10 CGY "LOW LEVEL"
|
|
MOST RADIOSENSITIVE CELL
|
LYMPHOCYTE
|
|
GI TRACK WITH THE LOWEST RADIOSENSITIVITY
|
COLON
|
|
TUMORS THAT HAVE HIGH RADIOSENSITIVITY
|
LYPHOMA, LUEKEMIA AND SEMINOMA
|
|
STAGE 3 CA CERVIX CA
|
EXTERNAL BEAM AND INTRACAVITARY IMPLANT TX
|
|
AS RADIOSENSITIVITY OF A TUMOR INCREASES
|
NORMAL TISSUE AND TUMOR LETHAL DOSE WILL DECREASE
|
|
GREATEST INCREAS IN RADIOSENSITIVITY WHEN OXYGEN IS GIVEN
|
DURING IRRADIATION TX
|
|
DURING ESOPHAGUS TX THE DIAPHRAGM IS NOT
|
A SENSITIVE INTRATHORACIC STRUCTURE
|
|
SKIN CANCERS
|
-BASAL CELL
-SQUAMOUS CELL -ACTINIC KERATOSIS -MELANOMA -KAPOSIS SARCOMA -CUTANEOUS T-CELL LYMPHOMA |
|
SIGNS/SYMPTOMS SKIN CA
|
-CHANGE OF SKIN
-BLEEDING -PAIN -PIGMENTATION |
|
RISK FACTORS SKIN CA
|
-UV RADIATION
-FAIR COMPLEXION -EXP TO COAL, TAR -FAMILY HISTORY -MULTIPLE MOLES |
|
ABCD OF SKIN CA
|
A- ASYMMETRY
B-BORDER IRRGULARITY C- COLOR D- DIAMETER > 6MM |
|
BASAL CELL CA
|
**MOST COMMON SKIN CA
-SUN EXPOSED AREAS -RARELY MET -90% H/N 5YR 95% |
|
BASAL CELL PRESENTS AS
|
NODULAR FORM- SMOOTH, SHINY, PEARLY GRAY
SUPERFICIAL FOR- ERYTHMATOUS, PLAQUE, CHEST/BACK |
|
SQUAMOUS CELL CA
|
-ERYTHEMATOUS, FIRM LESIONS, SCALY, CRUSTY
-SUN EXP AREAS -RARE METS 5 YR/ 90% |
|
ACTINIC KERATOSIS
|
-PREMALIGNANT STAGE SKIN CA
-RED, SCALEY PLAGUES -SCC ELSE WHERE 5YR/100% |
|
TX OF SKIN CA
|
-SURGURY=90%
-ELECTRODESSICATION -CRYOSURGURY -LASER THERAPY |
|
SKIN CA AND RADIOTHERAPY
|
**SITE**
-LESIONS WHERE SURGURY IS DIFFICULT NOSE, EYELID -OLD PT |
|
MALIGNANT MELANOMA
|
-ARISES IN MELANOCYTES
-MET TO LUNG, LIVER, BONE, BRAIN -SURGURY +- INTERFERON 5YR/88% |
|
LUNG CA RISK FACTORS
|
5YR/14%
-CIGARETTE -EXP TO INDUSTRIAL CHEM -ASBESTOS, ARSENIC, RADON |
|
LUNG CA SIGNS SYMPTOMS
|
-FATIGUE
-COUGH -CHEST PAIN -BLOOD IN SPUTUM -RECURRING PNEUMONIA -SOB -WEIGHT LOSS |
|
LUNG CA PATHOLOGY/ INCIDENCES
|
ADENO- 40%
SQUAMOUS- 30% SMALL CELL- 15% LARGE CELL- 15% |
|
LUNG CA METHOD OF SPREAD
|
LOCAL
LYMPH DISTANT |
|
LUNG CA METHOD SPREAD
|
HEMATOGENOUS:
OPP LUNG ADRENAL GLAND BONE MARROW BRAIN AND CORD NON SMALL CELL/ SMALL CELL PRESENT WITH DISSEMINATED DISEASE |
|
SVC SYNDROME
|
TUMOR GROWS AND OBSTRUCTS THE SVC, CAUSING SOB, SWELLING OF NECK/FACE/ARMS
DISTENDED VEINS OF THE CHEST/NECK |
|
LUNG CA EVAL
|
CXR
BLOOD TEST CT BRONCHO CT/NEEDLE BX BONE SCAN HEAD CT: SMALL CELL BONE MARROW BX |
|
LUNG CA STAGING
|
TNM
|
|
NON SMALL CELL PRIMARY TX
|
SURGURY IF POSSIBLE
|
|
SMALL CELL TX
|
CHEMO-PRIMARY
RAD THERAPY- USED WITH CHEMO TUMORS LIMITED TO THE CHEST |
|
RAD THERAPY SIDE EFFECTS LUNG CA ACUTE
|
ACUTE:
ESOPHAGITIS SKIN IRRITATION FATIGUE COUGH |
|
RAD THERAPY SIDE EFFECTS LUNG CA LATE
|
LATE:
PNEMONITIS PULM FIBROSIS SPINAL CORD DAMAGE PERICARDITIS |
|
LUNG CA SURVIVAL %
|
5 YR/ 14%- ALL STAGES
5 YR/ 49%- LOCALIZED |
|
GI ESOPHAGUS
|
BLACK > WHITE
ETOH/ SMOKING PATH: SCC & ADENO PRESENTS: DYSPHAGIA, WEIGHT LOSS, CHEST PAIN SPREAD: THRU WALL LYMPH NODES: MEDIASTINUM, SUPRACLAV, CELIAC METS: LUNG, LIVER, BONE |
|
GI ESOPHAGUS -WORK UP -TX
|
WORK UP- BAR SWALLOW, CT CHEST/ABD, ENDOSCOPY BX
TX: SURGURY, RAD DOSE 6000 CGY, CHEMO 5FU |
|
GI STOMACH
|
RISK: SMOKED/ SALTY FOODS, LOW VIT A+C
PRESENTS: MASS, BLEEDING, PAIN PATH: ADENO, SCC SPREAD: LYMPH NODES: INGUINAL OR PELVIS METS: PERITONEAL SURFACES, LIVER, LUNG |
|
GI STOMACH WORK UP/ TX
|
WORK UP: UGI SERIES, CT, ENDOSCOPY, BX
TX: SURGURY, RAD DOSE 45-50 GY, CHEMO |
|
GI ANAL CA
|
RISK: HIV, ANAL INTERCOURSE
PRESENTS: MASS, BLEEDING, PAIN PATH: ADENO, SCC SPREAD: LYMPH NODES- INGUINAL OR PELVIS METS: PERITONEAL SURFACES, LIVER, LUNG |
|
GI PANCREAS
|
RISK: SMOKE, CHRONIC PANCREATITIS
PRESENTS: ABD PAIN, NAUSEA, ANOREXIA, JAUNDICE |
|
GI PANCREAS WORK UP/ TX
|
WORK UP: CT, ERCP, LAPAROTOMY
TX: SURGURY- WHIPPLE PANCREATICODUODENECTOMY RAD DOSE: 50-60 GY CHEMO |
|
GI COLORECTAL
|
RISK: FAMILIA POLYPOSIS, INFLAM BOWEL DISEASE
PRESENTS: BLOOD IN STOOL, PAIN, CHANG IN BOWEL, BOWEL OBSTR PATH: ADENO SPREAD: LYMPH NODES, LIVER, LUNG |
|
GI COLORECTAL WORK UP/ TX
|
WORK UP: BE, SCOPYS, BX, CT, CXR
TX COLON: SURGURY, CHEMO TX RECTUM: RAD DOSE 45-50 GY, CHEMO |
|
GI RADIATION EFFECTS ACUTE
|
N/V
DIARRHEA FATIUGE DYSURIA |
|
GI RADIATION EFFECTS LATE
|
ENTERITIS
GASTRIC ULCER PROCTITIS SML BOWEL OBSTR |
|
GYN: INCIDENCES %
|
ENDOMETRIUM- 45%
OVARY- 30% CERVIX- 20% VULVA- 3-4% VAGINA- 1-2% |
|
GYN: ENDOMETRIUM
|
RISK: OBESITY, NULLIPARITY, LATE MENOPAUSE
PRESENTS: PAINLESS, VAG BLEEDING, 80% WITH TUMOR CONFINED TO UTERUS PATH: ADENO SPREADS: PELVIC LYMPH NODES, PARAORTIC, METS: LIVER, LUNG |
|
GYN: CERVIX
|
RISK: HIGH SEX PARTNERS, SEX EARLY AGE, EXPOSURE TO HERPES, TYPE 2 HPV
PATH: SCC, ADENO PRESENTS: VAG BLEEDING, PELVIC PAIN |
|
GYN STAGING CERVIX CA
|
FIGO STAGING SYSTEM
|
|
GYN: CERVIX TX
|
CONIZATION OR SIMPLE HYSTERECTOMY TAH-BSO
RADICAL TAH-BSO +- RT RT +- CHEMO |
|
GYN: CERVIX RT
|
EXT BEAM: 45-50 GY
INTRACAVITY T&O W/ CESIUM 137, DOSE TO POINT A 80-90 GY CHEMO |
|
GYN: OVARY
|
WOMEN > 55
PRESENTS: ADV PATH: ADENO PRESENTS: NAUSEA, LOWER ABD PAIN, BLOATING, VAG BLEEDING, OSS APPETITE |
|
GYN: OVARY
|
SPREAD: PERITONEAL SURFACES, RETROPERITONEAL, LIVER AND LUNG
WORK UP: PAP, BX, U/S, CT, CXR, LAPAROTOMY |
|
GYN: OVARY TX
|
SURGERY + CHEMO
RT (SELDOM) |
|
GYN: VAGINA
|
PRESENTS: VAG BLEEDING
PATH: SCC, CLEAR CELL ADENO, DES EXPOSURE WORK UP: BX, EXAM, CT, CXR |
|
GYN: VAGINA TX
|
TX:
SML LESIONS: SURGERY OR RT (INTRACAVITARY/INTERSTITIAL) ALL OTHERS: RT WITH RT/BRACHYTHERAPHY |
|
GYN: VULVA
|
PRESENTS: PAINFUL, BLEEDING, ITCHY, VULVAR LESION
PATHOLOGY: SCC WORK UP: BX, CT, CXR |
|
GYN: VULVA TX
|
SURGERY: RADICAL VULVECTOMY, INGUINAL NODE DISSECTION
|
|
GYN: SIDE EFFECTS ACUTE
|
ACUTE:
NAUSEA DIARRHEA FATIGUE DYSURIA SKIN IRRITATION |
|
GYN: SIDE EFFECTS LATE
|
LATE:
PROCTITIS RECTOVAGINAL FISTULA SML BOWEL OBSTRUCTION ENTERITIS |
|
RETICULOENDOTHELIAL SYSTEM
|
HODGKINS LYMPHOMA
NON HODGKINS LYMPHOMA ANN ARBOR STAGING |
|
RETICULOENDOTHELIAL SYSTEM TYPICAL PRESENTS
|
PAINLESS ENLARGEMENT OF LYMPH NODES WITH OR WITHOUT FEVER, WEIGHT LOSS, OR NIGHT SWEATS
|
|
HODGKINS SPREAD
|
CONTIGUOUS NODES
BONE MARROW LUNG LIVER |
|
NON HODGKINS SPREAD
|
DOES NOT SPREAD CONTIUOUSLY
OFTEN INVOLVES BONE MARROW EARLY MAY INVOLVE EXTRANODAL SITES AS GI TRACT, SKIN, BONE, BRAIN |
|
HODGKINS (BOTH) EVAL
|
CXR
CT BM BX LAPAROTOMY |
|
NON HODGKINS LYMPHOMA TX
|
SURGERY- BX FOR DX
CHEMO- USUAL TX RT + CHEMO FOR BULK DISEASE LOCALIZED- 30-50 |
|
STAGING HODGKINS
|
1- SINGLE SITE
2- 2 OR MORE ON SAME SIDE 3- BOTH SIDES 4- EVERYWHERE |
|
RETICULOENDOTHELIAL SYSTEM SIDE EFFECTS
|
BONE MARROW SURPRESSION
HYPOTHYROIDISM RADIATION PNEUMONITIS AND FIBROSIS RAD PERICARDITIS INDUCTION OF 2ND MALIGNANCIES (AML) |
|
CONNECTIVE TISSUE (CHONDRO/ LEIYOMYO)
|
ADIPOSE- LIPOSARCOMA
MUSCLE TISSUE- RHABDOMYOSARCOMA OR LEIYOMYOSARCOMA BLOOD VESSELS- KAPOSIS SARCOMA |
|
CONNECTION TISSUE
|
PRESENTS: WITH ASYMPTOMATIC MASS
SPREAD: ADJ LYMPH NODES, LUNG EVAL: CT, BONE SCAN, BX TX: SURGERY THEN XRT 55-68 GY CHEMO FOR METS KAPOSIS- LOCAL XRT (AIDS PT), LEAVE FLASH FOR LYMPHATICS TO WORK |
|
BONE CA
|
OSTEOSARCOMA
CHONDROSARCOMA FIBROSARCOMA |
|
BONE CA
|
PRESENTS: PAIN, SWELLING, MASS
SPREAD: LUNG EVAL: XRAYS, CT, MRI, BONE SCAN, BX TX: LIMB SPARING SURGERY OR AMPUTATION CHEMO FOR OSTEOSARCOMA RT FOR PALLIATION OR POSITIVE MARGINS |
|
PEDS CA
|
2ND LEADING CAUSE OF DEATH >15 YRS
ETIOLOGY: GENETIC, IONIZING RAD, DRUGS, VIRAL |
|
PEDS CA TYPE/INCIDENCES
|
#1- LEUKEMIA- 25%
CNS (MEDULLO/EPENDIMOMA)- 17% LYMPHOMAS- 16% CARCINOMAS AND EPITHELIAL- 9% GERM CELL TUMORS- 7% SOFT TISSUE SARCOMA 7% MALIGNANT BONE TUMORS- 6% RENAL TUMORS- 4% RETINOBLASTOMA- 2% |
|
PEDS CA: LEUKEMIA
|
TUMOR OF BONE MARROW
DISSEMINATES THRU BLOOD INVOVELS LN, CNS, TESTES, LIVER, SPLEEN TX: PRIMARILY CHEMO RT USED IN HIGH RISK PT TO THE BRAIN, SPINAL CORD, TESTES |
|
PEDS CA: WILM'S TUMOR:
|
INTRARENAL TUMOR
PRESENTS ABD MASS, PAIN, FEVER, HEMATURIA SPREAD: LN IN ABD, LIVER, LUNG TX: SURGERY- REMOVE KIDNEY INVOLVED CHEMO- VINCRISTIN/ACTINOMYCIN D RT- PTS WITH LNS, RESIDUAL DISEASE, METS TO LUNGS |
|
PEDS CA: NEUROBLASTOMA
|
TUMOR NEURAL CREST CELLS
IN ADRENAL GLAND/ SYMPHATHETIC GANGLIA SPREADS: LNS, LIVER, BONE MARROW, SKIN PRESENTS: ADB MASS, PAIN TX: SURGERY W/ CHEMO XRT: PALLIATION, DEBULK PREOP, STAGE 3, OR AFTER TRANSPLANT |
|
PEDS CA: MEDULLOBLASTOMA
|
TUMOR OF THE CEREBELLUM OR POST FOSSA
DISSEMINATES THRU CRANIAL SPINAL INRADURAL AXIS PRESENTS: NAUSEA, HEADACHES, VOMITT, LETHARGY, ATAXIS TX: SURGERY TO DEBULK FOLLOWED BY CRANIOSPINAL XRT OTHER CNS TUMORS REQUIRE CSA XRT- EPENDYMOMA IF SPINAL METS, PNET TUMORS, PIEAL REGION TUMORS (GERMINOMA) |
|
PEDS CA: COMPLICATIONS
|
SOFT TISSUE/ OSSEOUS HYPOPLASIA
PULMONARY FIBROSIS PSYCOMOTOR RETARDATION LEARNING DISABILITIES INFERTILITY ENDOCREINE DEFICITS INDUCTION OF 2ND MALIGNANCIES -OSTEOSARCOMA |
|
GENERAL RULE FOR LOCALIZATION IMAGING
|
SIMULATION IMAGES MUST VISUALIZE THE TREATED VOL WITH ASSOCIATED LANDMARKS AND FIELD PARAMETERS
|
|
IMAGING LABELING: MUST INCLUDE
|
PT FULL NAME
INSTITUTION, MD DATE VIEW FIELD PARAMETERS (FS, GANTRY/COLLIMATOR ANGLES) |
|
ORGANS AT RISK
|
ANATOMIC STRUCTURES WHICH SIGNIFICANTLY INFLUENCE DELIVERABLE DOSE TO PRESCRIBED VOLUME
|
|
VOLUME ENCLOSEDD BY ISODOSE SURFACE SPECIFIED BY RADIATION ONCOLOGIST AS APPROPRIATE TO ACHIEVE PURPOSE OF TX (PERSCRIPTION)
|
TREATED VOLUME
|
|
IMAGE RECEPTORS
|
98% OF IMAGE WILL BE CREATED BY LIGHT
|
|
FACTORS AFFECTING IMAGE QUALITY
|
RECEPTOR: FILM, SCREENS
GEOMETRY RAD EXPOSURE PROCESSING |
|
PENUMBRA
|
SHARPNESS IS A FUNCTION OF PENUMBRA
-FS SIZE -SAD (OR OBJECT), SID |
|
IMAGE QUALITY IN BEAM
|
CONTROLLED BY QUANTITY AND QUALITY
|
|
CONTRAST
|
GRAYSCALE, MEASURE OF RANGE FROM BLACK TO WHITE
|
|
DENSITY
|
MEASURE OF OVERALL BLACKNESS
|
|
EXPOSURE FACTORS: KVP
|
BEAM QUALITY=ENERGY=PENETRATING ABILITY
|
|
EXPOSURE FACTORS: MAS
|
BEAM QUANTITY=NUMBER OF PHOTONS
|
|
KVP & DENSITY
|
15% INCREASE IN KVP WILL DBL DENSITY
|
|
DENSITY & MAS
|
CURRENT: MA (COULOMB/SEC), - RATE OF E- PASSING THRU A CONDUCTOR
TIME OF EXPOSURE: S (SECONDS) EXPOSURE IS THE PRODUCT: MAS INCREASING MAS: INCREASES FILM DENSITY AND INCREASES PT DOSE |
|
FILM: LATENT IMAGE
|
INVISIBLE IMAGE FORMED BY CHANGES IN THE SILVER HALIDE CRYSTAL AS A RESULT OF EXP TO PHOTON ENERGY
|
|
FILM: MANIFEST IMAGE
|
VISIBLE IMAGE PRODUCED THRU CONVERSION OF REMAINING SILVER IONS IN EXPOSED CRYSTALS TO METALLIC SILVER
|
|
FILM PROCESSING
|
1-WETTING
2-DEVELOPEMENT 3-FIX 4-WASH 5-DRY |
|
VIRTUAL SIM
|
1- MARK TRIANGULATE REFERENCE POINT PRIOR TO SCAN
2- SCAN 3- PT NEED NOT BE PRESENT FOR REMAINDER 4- DEFINE TARGET 5- ESTABLISH ISOCENTER LOCATION FIELDS AND FIELD SHAPES RELATIVE TO PRE-SCAN REFERENCES (OFFSETS OR SHIFTS) |
|
SMALL VOLUMES IN CT
|
VOXELS
|
|
#1 PRIORITY WHEN PLANNING TO USE IV CONTRAST
|
PATIENT HISTORY
|
|
ANAPHYLAXIS AND EMERGENCY RESPONSE
MUST BE ON HAND |
PHYSICIAN
BENADRYL ADRENALYN CRASH CART |
|
CARDIAC ARREST AND CPR
|
1- VERIFY UNRESPONSIVENESS "ARE YOU OK"?
2- CALL FOR HELP 3- POSITION PT ON BACK AND HARD SURFACE 4- OPEN AIRWAY (FINGERS UNDER CHIN, HAND ON FOREHEAD, LIFTING JAW) |
|
CPR
|
LOOK, LISTEN, FEEL FOR BREATHING 5-10 SEC
|
|
CPR: COMPRESSIONS
|
HEEL OF HAND AT CENTER OF BARE CHEST, LOWER HALF OF STERNUM, LEVEL OF NIPPLES
30 COMPRESSIONS TO 2 BREATHS 2 RESCUERS SWITCH EVERY 2 MINUTES |
|
THE EXTERNAL AUDITORY MEATUS OVERLIES THE ANT BORDER OF THE
|
FORAMEN MAGNUM
|
|
THE LARYNX IS COINCIDENT WITH WHAT VERTEBRAL LEVEL
|
C4-C6
|
|
THE SUPERIOR EXTENT OF THE NASOPHARYNX MAY BE LOCATED LEVEL WITH THE
|
OUTER CANTHUS OF THE EYE
|
|
THE INFERIOR EXTENT OF THE HYPOPHARYNX IS LEVEL WITH THE
|
C6 & CRICOID CARTILAGE
|
|
THE COMMON ILIAC NODE CHAIN BRANCES FROM THE PARAAORTIC CHAIN AT THE LEVEL OF
|
L4 & ILIAC CREST
|
|
THE SPINAL CORD IN THE ADULT EXTENDS TO
|
L2
|
|
TO INCREASE RADIOGRAPHIC DENSITY ONE SHOULD
|
INCREASE MAS
|
|
TO INCREASE RADIOGRAPHIC CONTRAST ONE SHOULD DECREASE
|
KVP
|
|
ADVANTAGES OF NETWORKED DIGITAL IMAGE MANAGEMENT DO NOT INCLUDE
|
COMPUTER DISK SPACE IS NOT AN ISSUE
|
|
CONTRAST MEDIA MAY BE ADMINISTERED BY WHICH OF THE FOLLOWING
|
IV
ORAL CATHETER |
|
THE MOST COMMON TYPE OF SKIN CA IS
|
BASAL CELL CA
|
|
THE HISTOLOGIC TYPE OF LUNG CA WHICH IS OFTEN PRESENTS WITH METS IS
|
SMALL CELL
|
|
KREBS CYCLE
|
THE FINAL COMMON PATHWAY IN THE OXIDATION OF CARBOHYDRATE, PROTEIN AND FAT METABOLISM. IT IS THRU THIS CYCLE THAT ENERGY IS RELEASED
|
|
H&N FOOD SUGGESTIONS
|
VERY SOFT TO THICK LIQUIDS, MOIST TEXTURES
TEMP: WARM TO COOL SEASONINGS: MILD, NON ACIDIC |
|
CANCER CELLS CAN PRODUCE MORE THAN 40 TIMES MORE ________ THAN NORMAL CELLS
|
LACTIC ACID
|
|
RADIATION TO INTESTINAL AREA
|
LOW FIBER
LOW FAT LOW LACTOSE INCREASE FLUIDS |
|
FOR NAUSEA
|
LOW FIBER
LOW FAT FREQUENT SNACKS |
|
FOR VOMITING
|
CLEAR LIQUIDS
PUSH FLUID INCREASE SODIUM CONTAINING LIQUIDS |
|
TO PREVENT DENTAL CARIES WITH XEROSTOMIA NEVER USE
|
REGULAR CANDIES OR GUM OR ANY HIGH SUGAR CONTENT FOOD
|
|
SERUM ALBUMIN
|
IS AN INDICATOR OF VISCERAL PROTEIN STORES
|
|
URINE CREATININE
|
EXTRETED IN LARGE AMOUNT IN CONDITIONS WHERE THERE IS BODY PROTEIN BREAKDOWN
|
|
TUBE FEEDING RISKS
|
THE PUMP SHOULD BE OFF 1/2 HOUR TO 45 MIN BEFORE PERSON LIES DOWN FLAT
BECAUSE INCREASED RISK OF ASPIRATION |
|
CANCER CACHEXIA
|
A CLINICAL SYNDROME THAT DEVELOPES WHEN THERE IS NUTRITIONAL AND METABOLIC ABNORMALITIES IN ADVANCED CANCERS
|
|
PSYCHOLOGICALLY RELATED
|
DEPRESSION
SOCIALIZATION DISRUPTED FINANCIAL BURDEN INCREASED |
|
PATIENT BILL OF RIGHTS
|
RESPECT
QUALITY HEALTH CARE INFO YOU CAN UNDERSTAND CARE FOR YOU AND YOUR FAMILY PARTICIPATE IN DESCISIONS EMOTIONAL SUPPORT |
|
CODE OF ETHICS IN RAD THERAPY
|
INFORMED CONSENT
CONFIDENTIALITY HIPPA |
|
BENEFICENCE
|
DOING GOOD
|
|
NONMALEFICENCE
|
PREVENTING HARM
|
|
AUTONOMY
|
RESPECTING OTHER'S INDEPENDENCE
|
|
VERACITY
|
TELLING THE TRUTH
|
|
FIDELITY
|
BEING FAITHFUL
|
|
JUSTICE
|
BEING FAIR OR EQUITABLE
|
|
MALPRACTICE
|
IMPROPER TX OF A PT RESULTING IN INJURY, DAMAGE, OR LOSS
|
|
NEGLIGENCE
|
FAILURE TO USE SUCH CARE AS A REASONABLE PRUDENT PERSON WOULD USE UNDER LIKE CIRCUMSTANCES
|
|
BATTERY
|
UNLAWFUL TOUCHING WITHOUT CONSENT
|
|
ASSAULT
|
THREAT OF TOUCHING TO INJURE
|
|
RES IPSA LOQUITOR
|
A RULE OF EVIDENCE WHEREBY THE NEGILGENCE OF AN ALLEGED WRONGDOER CAN BE INFERRED FROM THE FACT THAT THE ACCIDENT HAPPENED
|
|
RESPONDEAT SUPERIOR
|
THE EMPLOYER IS RESPONSIBLE FOR NEGLIGENT ACTS OF ITS EMPLOYEES
|
|
SIDE EFFECTS OF RAD THERAPY
|
SKIN REACTIONS:
DRY, ITCH, BURNING ERYTHEMA (2000 CGY) DRY DESQUAMATION MOIST DESQUAMATION |
|
CEREBRAL EDEMA
|
DESTRUCTION OF BLOOD-BRAIN BARRIER
WHOLE BRAIN XRT LIMB WEAKNESS VISUAL CHANGES SEIZURES SPEECH PROB |
|
ALOPECIA
|
HAIR FOLICLES HAVE HIGH MITOTIC RATE
OCCURS AT 2400 CGY REGROWHT 3-6 MO LOSS PERMANENT > 6000 CGY |
|
MUCOSITIS
|
MUCOS MEMBRANE VERY RADIOSENSITIVE
METAL FILLINGS INCREASE REACTION DUE TO SCATTER USUALLY 2-3 WKS IN RT (3000 CGY) INCREASED WITH CHEMO |
|
MUCOSITIS RISK FACTORS/ MANAGEMENT
|
RISK FACTORS: POOR NUTRITION AND ORAL HYGIENE, CONT TOBACCO/ETOH, POOR FITTING DENTURES
MANAGEMENT: SEE DENTIST FIRST SALINE/BAKING SODA RINSE QID SOFT TOOTHBRUSH DIETARY CONSULT |
|
XEROSTOMIA
|
SALIVARY GLANDS EXTREMELY RADIOSENSITIVE
SALIVA BECOMES THICK AND ROPY RISK FOR DENTAL CARRIES/ INFECTIONS DOSE AS LITTLE AS 10 GY CAN DECREASE SALIVA OUTPUT 60-90% |
|
XEROSTOMIA MANAGEMENT
|
MODIFY DIET
INCREASE FLUID PILOCARPINE AMIFOSTINE |
|
DYSGUESIA
|
TASTE CHANGES
TASTE BUDS ARE RADIOSENSITIVE |
|
HEARING CHANGES
|
RARE
OCCUR IF MIDDLE EAR IS IN TX FIELD |
|
OSTEORADIONECROSIS: DELAYED
|
DECREASED VASULARITY/CELLULARITY OF BONE
WEAKENS BONE MANDIBLE VER SENSITIVE CAN OCCUR 6 MO AFTER RT PAIN OR FRACTURE |
|
TRISMUS; DELAYED
|
CONTRACTION OF THE JAW MUSCLE FROM FIBROSIS
OCCURS FEW MO TO YRS AFTER RT |
|
CHEST/LUNG SIDE EFFECTS
RADIATION PNEUMONITIS: ACUTE |
DAY TO WKS OF STARTING RT
ENDOTHELIAL LINING BEGINS TO SLOUGH AND CAN OCCLUDE THE LUMEN OF THE LUNG |
|
CHEST/LUNG SIDE EFFECTS
|
RADIATION PNEUMONITIS
PULMONARY FIBROSIS |
|
COLLABORATIVE MANAGEMENT
|
NUTRITION CONSULT
WEEKLY WEIGHTS CONTROL CONTRIBUTING SYMPTOMS: NAUSES, DIRRHEA |
|
ABD RT: SIDE EFFECTS
|
ANOREXIA
N/V PREMEDICATE |
|
PELVIC RT: SIDE EFFECTS
|
DIARRHEA
PROCTITIS FREQ URINATION DYSURIA SEX DYSFUNCTION SKIN REACTIONS |
|
RED BLOOD CELLS
|
CARRY OXYGEN TO CELLS THRU OUT BODY
|
|
NORMAL RBC VALUE
|
HEMATOCRIT: 37-51%
HEMOGLOBIN: 12-18 G/DL |
|
WBC'S
|
HELP THE BODY FIGHT INFECTION
NORMAL VALUE: 4,000-11,000 K/UL |
|
PLATELETS
|
HELP BODY TO STOP BLEEDING
NORMAL: 150,000 -400,000 K/UL |
|
FACTORS THAT AFFECT BLOOD COUNTS
|
MEDICATIONS
UNDERLYING MED CONDITION RADIATION- PREVIOUS AND CURRENT CHEMO CA IN BONE MARROW NUTRITION |
|
FEEDING TUBES
|
NO FEEDINGS WHILE LAYING DOWN
|
|
ASEPSIS
|
MEDIAL- REDUCE NUMBER OF INFECTOUS AGENTS
SURGICAL- STERILE TECH |
|
PATHOGEN
|
ANY DISEASE PRODUCING ORGANISM
|
|
STANDARD PRECAUTIONS
|
AIRBORNE: TB, CHICKEN POX
CONTACT: C. DIFFICILE DROPLET: INFLUENZA STRICT: SARS, SMALL POX |
|
BREAST FIELDS
|
TANGENTS
CHEST WALL SUPRA CLAV INTERNAL MAMMARY NODES AXILLARY NODES |
|
BREAST
|
2ND -6TH RIB FROM STERNUM
TAIL OF SPENCE 15-20 LOBES EMBEDDED IN ADIPOSE TISSUE DRAINED BY DUCTS THAT OPEN AT NIPPLE LOBE CONTAINS LOBULES |
|
BREAST LYMPHATICS
|
AXILLARY
IM TRANSPECTORAL SUPRACLAVICULAR |
|
BREAST TANGENT BORDERS
|
SUP: 1ST OR 2ND INTERCOSTAL SPACE
INF: 1.5 CM BELOW INFRAMAMMARY FOLD MEDIAL: MIDLINE OR 1.5 OVER MIDLINE LAT: NEAR MID AXILLARY LINE, 2 CM BEYOND BRST TISSUE CO-PLANER EDGE SML VOL OF LUNG INCL NO LUNG |
|
BREAST: SUPRACLAV
|
SUP: ACROSS NECK AND TRAP TO ACROMIAL PROCESS
INF: 1ST OR 2ND INTERCOSTAL SPACE MED: 1 CM LAT ACROSS MIDLINE TO UNAFFECTED SIDE LAT: AC JOINT, BISECTING HUMERAL HEAD, S/C NODES TO 2/3 OF CLAVICLE |
|
BREAST: SUPRACLAV
|
ANGLED 10-15* TOWARD UNAFFECTED SIDE
ANT OBL MOST COMMON LOWER PORTION OF FIELD BLOCKED WITH 1/2 BEAM OR ASYMMETRIC JAWS |
|
BREAST: E- CHEST WALL BORDERS
|
MED: MATCHING IM NODES REQ TX
LAT: MID AXILLARY SUPERIOR: MATCH INF SUPRACLAV INF: HORIZONTAL LINE AT LEVEL OF XYPHOID |
|
BREAST: INTERNAL MAMMARY BORDERS
|
MED: MIDLINE OR 1 CM OVER MIDLINE
LAT: 5-6 CM LAT TO MIDLINE SUP: ABUTS THE INF BORDER OF SUPRACLAV INF: XYPHOID |
|
PAB FIELD BORDERS
|
MED: 1.5 -2 CM OF LUNG, INCLUDE AXILLARY NODES CLOSE TO CHEST WALL
LAT: 1 -2 CM OF HUMERAL HEAD, LATISSIMUS DORSI MUSCLE SUP: BISECT CLAVICLE AND HUMERAL HEAD INF: MATCHES SUP BORDER OF TANGENTS |
|
BREAST TX DOSE & ENERGY
|
4-6 MV
180-200 CGY/FX TOTAL DOSE: 45-50 GY BOOST TANG W/ E- OR CONE DOWN PHOTON TO 60-66 GY |
|
LOBES LUNG
|
RIGHT: 3 LOBES
LEFT: 2 LOBES |
|
MEDIASTINUM: SUP & INF (ABOVE AND BELOW CARINA)
|
CONTAINS ALL ORGANS EXCEPT LUNGS:
HEART AORTA (T2) PULM TRUNK, VEINS, ARTERIES INF VENA CAVA TRACHEA MAIN BRONCHI ESOPHAGUS THYMUS GLAND NERVES |
|
RESPIRATORY LYMPHATICS
|
INTRAPULMANARY
HILAR MEDIASTINAL: SUP & INF INF PULMANARY LIGAMENT |
|
LYMPHATIC DRAINAGE: LUNG
|
LLL TO SUBDIAPHRAGMATIC ORGANS
BOTTOM OF LUL TO SUBDIAPHRAGMATIC ORGANS RUL TO AXILLA ENTIRE LUNGS UP THE MIDLINE CHAIN OF NODES |
|
H&N ANATOMY
|
ORAL CAVITY
NASOPHARYNX OROPHARYNX HYPOPHARYNX LARYNX LYMPH NODES PAROTID SINUSES |
|
ESOPHAGUS LYMPHATICS; RICH LONGITUDINAL INTERCONNECTING LYMPHATIC SYSTEM
|
UPPER: MOST COMMON TO THE INTERNAL JUGULAR, CERVICAL, OR SUPRACLAV LN'S
MIDDLE: PRIMARILY TO SUPRACLAV, PARATRACHIAL AND MEDIASTINAL NODES LOWER: LOWER MEDIASTINAL, GASTRIC AND CELIAC AXIS ODES |
|
STOMACH LYMPHATICS
|
SPREAD IS VIA **DIRECT EXTENSION
LYMPHATICS, HEMATOGENOUS SPREAD AND SPILLAGE INTO PERITONEAL CAVITY |
|
STOMACH BORDERS: AP/PA FIELDS
|
SUP: 3-4 CM MARGIN
INF: BOTTOM L3 LAT: 3-4 CM MARGIN AROUND THE TUMOR OR TUMOR BED **EXCLUDE 3/4 OF ONE KIDNEY |
|
PANCREAS ANATOMY
|
RETROPERITONEAL
LEVEL L1-L2 HEAD OF PANCREAS IN DUODENUM TAIL EXTENDS TO SPLENIC HILUM |
|
PANCREAS LYMPHATICS
|
SUP & INF PANCREATICODUODENAL NODES
PORTA HEPATIS SUPRAPANCREATIC NODES CELIAC NODES ADJ PARA-AORTIC NODES **ALSO SPREADS VIA DIRECT EXTENTION |
|
PANCREAS
|
4 FIELD DOSE 45-50 GY W/ 5FU
MANY DOSE LIMITING ORGANS: SML INTESTINES, STOMACH, LIVER, KIDNEYS, SPINAL CORD |
|
RECTUM ANATOMY
|
LOCATED BETWEEN SIGMOID AND ANUS
13-15 CM LONG 3 SECTIONS: UPPER, MIDDLE, LOWER 3RD RECTUM/SIGMOID JOIN AT S3 |
|
RECTUM LYMPHATICS
|
UPPER RECTUM FOLLOW SUP RECTAL VESSELS AND TERMINATES IN INF MESENTERIC NODES
MIDDLE & LOWER: RECTAL LN'S DRAIN TO THE INTERNAL ILIAC AND PRESACRAL NODES |
|
RECTUM PORTS
|
MIXED ENERGIES
PA: LOW ENERGY LATS: HIGH DOSE 45-50 GY |
|
ANAL CANAL ANATOMY
|
3-4 CM LENGTH
|
|
ANAL CANAL LYMPHATICS: 3 LYMPH NODE SYSTEMS
|
PERIANAL SKIN, ANAL VERGE, AND CANAL- SUPERFICIAL INGUINAL NODES AND TO EXTERNAL ILIACS
UPPER CANAL- CAN SPREAD TO INTERNAL ILIACS (HYPOGASTRIC) TUMORS OF THE UPPER CANAL AND TRANSITIONAL ZONE- MAY TRAVEL TO THE INFERIOR MESENTERIC NODES |
|
ANAL CANAL PORTALS
|
AP/PA OR 4-FIELD
AP SOMETIMES LARGER FOR INGUINAL NODES BOOST INGUINAL NODES WITH E- BOOST ANUS BENT OVER ON ANGLE BOARD DOSE 4500 CGY |
|
GYN LYMPHATICS
|
3 SEP ROUTES
1. LAT: ALONE UTERINE TO EXT ILIACS 2. POST-LAT: BEHIND URETERS TO INT ILIAC NODES 3. POST: ENTER COMMON ILIAC AND LAT SACRAL |
|
OVARY LYMPHATICS
|
1. PARA-AORTIC
2. EXT. ILIAC 3. INT. ILIAC |
|
UTERUS LYMPHATICS
|
1. COMMON ILIAC
2. INT ILIAC 3. EXT ILIAC 4. PARA-AORTIC |
|
VAGINA LYMPHATICS
|
1. INT ILIAC
2. EXT ILIAC 3. SUPERFICIAL INGUINAL |
|
VULVA LYMPHATICS
|
1. INGUINAL
2. DEEP FEMORAL NODES 3. EXT ILIAC |
|
CERVIX BRACHY POINTS: POINT A
|
2 CM SUP TO EXT OS AND 2 CM LAT TO CERVICAL CANAL
|
|
CERVIX BRACHY POINTS: POINT B
|
2 CM SUP AND 5 CM LAT TO EXT OS
|
|
BLADDER LYMPHATICS
|
EXT AND INT ILIAC
PRESACRAL NODES |
|
BLADDER DOSE
|
1ST COURSE: 45-50 GY
CONE DOWN: 5-70 GY |
|
PROSTATE ANATOMY
|
PROSTATE GLAND COMPOSED OF 5 LOBES
URETHRA PASSES THRU LOCATED BELOW BLADDER |
|
PROSTATE LYMPHATICS
|
INT ILIAC
EXT ILIAC |
|
PROSTATE DOSE
|
TOTAL 75-81 GY W/ CONFORMAL FIELDS
|
|
PROSTATE SEED IMPLANTS:
|
125 IODINE AND 103 PALLADIUM
|
|
WILMS TUMOR
|
ORIGINATES IN THE KIDNEY
LOCATED RETROPERITONEAL SPACE BTWN 11TH RIB & L3 RIGHT KIDNEY GENERALLY 1-2 CM LOWER BECAUSE OF LIVER |
|
TESTICULAR LYMPHATICS
|
PURE SEMINOMAS PRIMARILY SPREAD THROUGH LYMPHATICS
PARA AORTIC NODES ILIAC NODES |
|
LUNG METS
|
XRT ENTIRE LUNG VOLUME
INCLUDE LUNG BASES |
|
TESTICULAR BORDERS
|
HOCKEY STICK
DOSE 25-30 GY |
|
HODGKINS LYMPHATICS
|
**ALWAYS BEGINS IN LYMPH NODES
SPLEEN THYMUS WALDEYER'S RING (TONSILS, ADENOIDS,) PEYER'S PATCHES: SML BOWEL: NEAR ILEUM AND COLON JUNCTION |
|
HODGKINS POSITION
|
MANTLE
ARMS AKIMBO OR RAISED ABOVE HEAD CHIN HYPEREXTENDED DOSE 40 GY |
|
HODGKINS IS BIMODAL
|
15-30 YR
THEN 50+ YRS |
|
SARCOMA
|
ARRISE CONNECTIVE TISSUE OF BODY
INCLUDE: MUSCLES, TENDONS, FAT, FIBROUS AND SYNOVIAL TISSUE 60% ARISE IN EXTREMITIES |
|
TX CONSIDERATIONS FOR BONE
|
SPARING A STRIP: 1.5-2 CM TO LIMIT DISTAL EXT EDEMA
SPARE GROWTH PLATE IF POSSIBLE |
|
ORAL CAVITY SONG
|
OH MY NAME IS ORAL, ORAL CAVITY I AM MADE OF MANY PARTS.
I START FROM THE LIPS TO THE HARD PALATE, INCLUDING PART OF THE TONGUE. MY PARTS ARE BUCCAL MUCOSA, RETROMOLAR TRIGONE TOO. GINGIVA AND FLOOR OF MOUTH ARE ALL A PART OF ME. I AM THE ORAL CAVITY. |
|
OROPHARYNX SONG
|
OH, IM THE OROPHARYNX AND I HAVE SEVERAL PARTS.
I START FROM THE SOFT PALATE TO THE HYOID INCLUDING THE UVULA. MY PARTS ARE THE ORPHARYEAL WALL, VALLECULAE, AND BASE OF TONGUE. THE BORDER OF THE EPIGLOTTIS AND TONSIL ARE WITHIN ME. I AM THE OROPHARYNX |
|
LARYNX SONG
|
OH, IM THE LARYNX OR THE VOICE BOX AND I HELP TO MAKE THE SOUND. THE THYROID CARTILAGE COVERS ME FROM THE FRONT AND ON BOTH SIDES. THY CRICOID CARTILAGE CIRCLES ME JUST BELOW THE VOCAL CORDS. SUPRAGLOTTIS, SUBGLOTTIS AND THE GLOTTIS MAKES ME
I AM THE LARYNX OR VOICE BOX. |
|
HYPOPHARYNX SONG
|
OH IM THE HPOPHARYNX AND I ENVELOP THE LARYNX. I ALSO HAVE SOME DIFFERENT PARTS COMPRISING ONLY OF THREE.
I HAVE THE PERIFORM SINUS, POSTCRICOID AREA. POSTERIOR PHARYNGEAL WALL IS THREE AND THATS WHAT MAKES ME. I AM THE HYPOPHARYNX |
|
NASOPHARYNX SONG
|
OH IM THE NASOPHARYNX JUST POSTERIOR TO THE NASAL CAVITY.
THE SOFT PALATE AND THE UVULA ARE THE BORDER TO THE 2ND CERVICAL VERTEBRA. THE SPHENOID SINUS IS SUPERIOR, EUSTACHIAN TUBES ARE LATERAL. THE POSTERIOR PHARYNGEAL WALL IS LAST OF THE BORDERS. I AM THE NASOPHARYNX. |
|
WHY WOULD YOU USE AN ANGLE BOARD
|
TO REDUCE PT SLOPE, TO ELIMINATE OR REDUCE COLLIMATOR ANGLE
ON LRG BRST SHIFT THE BREAST TISSUE INF |
|
WHICH LEVEL AXILLARY NODES (I,II,III) LIE SUP TO THE PECTORALIS MINOR MUSCLE.
|
LEVEL III
|
|
WHICH TECHNIQUES MAY BE USED TO TREAT THE INT MAMMARY LYMPH NODES ON A PT WITH LEFT BRST CA AND DELIVER THE LEAST CARDIAC DOSE
|
ANT PHOTON/E- FIELDS, 50 GY/5 WKS
|
|
AXILLARY NODES DRAIN INTO WHAT
|
SUPRACLAV NODES
|
|
INTERNAL MAMMARY NODES ARE PRIMARILY LOCATED
|
IN THE 1ST, 2ND, 3RD, AND 6TH INTERCOSTAL SPACE
|
|
CRITICAL STUCTURES LOCATED IN THE TX FIELD FOR LUNG CA INCLUDE?
|
SPINAL CORD
HEART |
|
AP/PA OPPOSED PORTAS OF THE SUPERIOR CHEST CAUSES
|
A HIGHER DOSE NEAR SUP EDGE OF THE FIELD AS COMPARED WITH THE CAX
|
|
THE SUP BORDER FOR A T1 LARYNX FALLS AT
|
HYOID BONE
|
|
T/F: THE JOGULODIGASTRIC NODES FALL POST TO THE CERVICAL NODES
|
FALSE
|
|
PAROTIC GLANDS TUMORS MAY BE TX WITH
|
3 FIELD HEAD AND NECK
|
|
STOMACH LYMPHATICS DRAIN TO THE
|
CELIAC AXIS
|
|
LOWER RECTUM LYMPHATICS DRAIN TO
|
INT ILIACS AND PRESACRAL NODES
|
|
GYN: WHY USE A MIDLINE BLOCK? (3)
|
1. BOOST PARAMETRIAL NODES
2. BLOCK IMPLANT AREA 3. BLOCK BLADDER AND RECTUM |
|
STATE THE TYPICAL FIELD ARRANGEMENT + FIRST COURSE DOSE USED FOR ESOPHAGUS AND THEN THE FIELD ARRANGEMENT USED FOR THE BOOST
|
1ST COURSE: AP/PA TO 3000 CGY
BOOST: AP & 2 POST OBL |
|
THE VAGINA DRAINS INTO WHICH LYMPHATICS
|
INT & EXT ILIACS AND SUP INGUINALS
|
|
THE NODE OF CLOGUET IS LOCATED WHERE?
|
DEEP FEMORAL
|
|
TOTAL DOSE PRESCRIBED FOR A WILMS TUMOR FIELD IS WHAT?
|
1000-2000 CYG
|
|
TESTICULAR LYMPHATICS DRAIN TO WHERE
|
PARA AORTICS
|
|
THE BLADDER DRAINS TO WHAT LYMPHATICS
|
EXT & INT ILIACS
|
|
HODGKINS: IN ADDITION TO THE BLOCKS USED FORM THE FIRST DAY OF TX, WHAT TWO CRITICAL STRUCTURE BLOCKS DO WE ADD AS WE NEAR THEIR TOLERANCE DOSE AND STATE THE TOLERANCE DOSE FOR EACH
|
LARYNX- AP 2000 CGY
SPINE- PA 3000 CGY |
|
HODGKINS: THE ANATOMY OF WALDEYERS RING IS COMPOSED OF
|
TONSILS, ADENOIDS, BASE OF TONGUE
|
|
HODGKINS: THE SHAPE OF THE PARA-AORTIC AND PELVIC FIELDS TOGETHER IS CALLED WHAT
|
INVERTED Y
|
|
THE PITUITARY IS LOCATED IN WHAT STRUCTURE
|
SELLA TURSICA
|
|
WHEN TREATING A CRANIOSPINAL FIELD ___ MUST BE INCLUDED ON THE SUP ASPECT OF THE BRAIN TO BE SURE ___ ARE INCLUDED
|
CRIBIFORM PLATE
MENINGIES |
|
WHAT DO WE CALL THE TECHNIQUE USED TO REDUCE THE CHANCES OF A PT EXPERIENCING LYMPHEDEMA?
|
SPARING A STRIP
|
|
WHEN USING CRANIOSPINAL IRRADIATION, TO ELIMINATE DIVERGENCE OF THE SPINAL FIELD YOU MUST
|
ROTATE THE TABLE TOWARDS THE GANTRY
|
|
THE AREA OF GROWTH IN BONE IS CALLED WHAT
|
EPIPHYSEAL PLATE
|
|
ISOCENTER IS DEFINED AS THE POINT
|
-THE GANTRY ROTATES AROUND
-THE COLLIMATOR ROTATES AROUND -WHERE ALL THE LASERS MEET |
|
THE FIELD WIDTH OF THE TX BEAM IS DEFINED BY ___ ISODOSE LINE
|
50%
|
|
A 100 CM TX UNIT IMPLIES
|
THE FIELD SIZE IS DEFINED BY THE COLLIMATOR IS DEFINED AT 100 CM
|
|
WHICH OF THE FOLLOWING NORMALLY PREVENTS THE OPERATION OF A THERAPEUTIC UNIT
|
NOT ANY OF THESE
PT MOVING FIELD SIZE MISALIGNMENT IMPROPER GANTRY ANGLE |
|
THE REDUCTION OF PRIMARY BEAM TRANSMISSION TO A LEVEL OF LESS THAT 5% WILL GENERALLY REQUIRED HOW MANY HVL
|
5 HVL
|
|
TX MACHINE BEAM MODIFIERS
|
WEDGE POSTITION
COMPENSATORS IMRT BOLUS BLOCKS/TRAYS MLC'S |
|
LIGHT FIELD/ RADIATION COINCIDENCE TEST ARE DONE TO
|
PREVENT GEOGRAPHIC MISS OF TUMOR
|
|
WHICH OF THE FOLLOWING ARE POSSIBLE SOURCES OF LIGHT FIELD INCONGRUENCE?
|
MIRROR MISALIGNMENT
COLLIMATION MISALIGNMENT |
|
THE BLOCK TRANSMISSION PENUMBRA CAN BE REDUCED BY
|
EMPLOYING DIVERGENT BLOCKS
|
|
THE DISTANCE A BLOCK SHOULD BE FROM A PT IS
|
15-20 CM
|
|
WHAT THICKNESS OF CERROBEND EQUIVILANT TO 6 CM OF PURE LEAD?
|
7.5 CM
|
|
A BOLUS IS APPLIED IN E- BEAM THERAPIES TO INCREASE
|
SURFACE DOSE
|
|
BOLUS IS USED IN MV THERAPY TO
|
INCREASE SKIN DOSE
|
|
THE HINGE ANGLE IS THE ANGLE
|
BETWEEN THE CENTRAL AXES OF 2 WEDGED BEAMS
|
|
TWO TX FIELDS HAVE A HINGE ANGLE OF 90* CALCULATE THE WEDGE ANGLE
|
45*
|
|
IN GENERAL, THE ACCEPTABLE AMOUNT OF PRIMARY BEAM TRANSMISSION THROUGH BLOCKS IS
|
5%
|
|
IN GENERAL, THE ACCEPTABLE AMOUNT OF PRIMARY BEAM TRANSMISSION THROUGH THE MLC'S
|
1-2%
|
|
T/F: DO MLC'S COMPLETELY ELIMINATE THE NEED FOR CERROBEND BLOCKS
|
FALSE
|
|
4 REASONS TO MONITOR THE PT
|
PATIENT SAFETY
ACCURACY OF TX PT MOTION MACHINE COLLISION |
|
T/F A RECORD AND VERIFY COMPUTER BASED PROGRAM CAN IDENTIFY SET-UP ERRORS PRIOR TO TX
|
TRUE
|
|
ALL OF THE FOLLOWING ARE IMPORTANT PUPOSES FOR LABELING VERIFICATION IMAGES
|
PORT FILMS ARE LEGAL DOCUMENTS
DOCUMENTATION OF TX RECORD PROVIDES A MEANS TO ENACT CHANGE |
|
A MECHANISM FOR ENSURING THAT RADIAITON BEAMS ARE IRRADIATING THE ENTIRE PREDETERMINED VOLUME IS BY
|
TAKING PORT FILMS
|
|
WHILE TX A PT USING A ROTATIONAL TECHNIQUE, THE GANTRY ROTATES PAST THE END POINT. THIS IS MOST LIKELY A MALFUNCTION OF THE
|
LIMIT SWITCH
|
|
ALL OF THE FOLLOWING UNITS USE A TIMER TO TERMINATE RADIATION EXPOSURE EXCEPT
|
LINEAR ACCELERATOR
|
|
T/F TO PROCEED W/ TX WHEN THERE ARE FAULT LIGHT INDICATORS DURING THE WARM-UP PROCEDURE CAN CAUSE SERIOUS DAMAGE TO THE MACHINE AND THE PT.
|
TRUE
|
|
WHAT IS THE FIRST STEP IF A TX BEAM FAILS TO TERMINATE
|
BEAM OFF
|
|
T/F EMERGENCY OFF SWITCHES SHOULD BE ACTIVATED PERIODICALLY AND WHEN THERE IS EVIDENCE OF SERIOUS MALFUNCTION
|
TRUE
|
|
ALL OF THE FOLLOWING APPLY TO BACK UP TIMERS
|
FOUND ON CONTROL PANEL
SET ALON WITH THE MAIN TIMER SET FOR A LONGER PERIOF OF TIME THAN THE MAIN TIMER |
|
T/F INTERLOCKS ARE PROTECTIVE DEVICE DESIGNED TO SHUT DOWN A SYSTEM IF IT ISN'T OPERATING PROPERLY
|
TRUE
|
|
IF A LINE POWER FAILURE OCCURES ON A LINEAR ACCERLATOR DURING TX, WHAT PROCEDURE SHOULD YOU FOLLOW
|
RESET BREAKER
DETERMINE THE NUMBER OF MONITOR UNITS ALREADY USED AND CONTINUE TX |
|
INCLUDED IN THE TX RECORD
|
MU/TIME
TUMOR DOSE/DAILY TUMOR DOSE/ ACCUM BEAM ENERGY BEAM TYPE SET-UP INSTRUCTIONS DATE FRACTION ELAPSED DAYS FIELD NUMBER DOSE TO OTHER POINTS TIME (BID) |
|
MISADMINISTRATION WITH COBALT 60
|
-WRONG SITE, PT, MODE OF TX
-MISADMIN >10% OF TOTAL DOSE (<4 FX) -MISADMIN > 20% OF TOTAL DOSE (>3FX) -MISADMIN > 30% OF WEEKLY DOSE |
|
MISADMINISTRATION MACHINE
|
ANY TX MACHINE > 2%
|
|
WHICH OF THE FOLLOWING ARE AREAS OF RESPONSIBILITY FOR THE RADIATION THERAPIST IN INDENTIFICATION AND MANAGEMENT OF MACHINE MALFUNCTIONS
|
-RADIATION
-ELECTRICAL -MECHANICAL |
|
STENTS AND BITE BLOCKS ARE EX OF ___ TX DEVICE CHARGE
|
INTERMEDIATE
|
|
A PT IS BEING TREATED TO TWO SEP AREAS, OPEN FIELD PA SPINE AND AP/PA HUMERUS WITH NO BLOCKS. CHARGE?
|
INTERMEDIATE
|
|
TX OF 6X SPINE FIELD WITHOUT BLOCKS IS WHAT CHARGE
|
SIMPLE
|
|
TX OF A E- SCAR AREA FIELD WITHOUT A CUSTOM INSERT IS WHAT CHARGE
|
COMPLEX
|
|
BRST CA SCREENING
|
START @ 40 ANNUALLY
IMAGING: MAMMOGRAPHY US MRI PET FOR STAGING METS |
|
BRST CA HISTOLOGIC TYPES
|
INFILTRATING LOBULAR CA
INFILTRATING DUCT CA IN SITU DUCT CA |
|
RADIATION TECH- BREAST CONSERVATION
|
TANG/ IMRT
E- BOOST NODAL RT- AXILLA, SUPRACLAV, BOTH |
|
RADIATION TECH- PARTIAL BREAST RT
|
HDR CATHETERS
BALLOON MAMMOSITE EXT PBI |
|
RADIATION TECH- POST MASTECTOMY
|
CHEST WALL TANG, E-
NODAL RT |
|
MAMMOSITE
|
BALLOON PLACED IN LUMPECTOMY CAVITY DURING SURGERY
3400 CGY IN 5 DAYS 340 CGY X 10 (BID) |
|
CHEMO BREAST
|
TAMOXIFEN
ARIMIDEX FEMARA |
|
BREAST DOSE
|
180-200 CGY/DAY
4600-5000 CGY WHOLE BRST BOOST 6000-64000 CGY TOTAL TO INVOLVED SEGMENTS WITH MARGIN |
|
PROSTATE PSA
|
DRE @50
40 HIGH RISK |
|
KIDNEY
|
CLEAR CELL CA
|
|
RENAL PELVIS
|
TRANSITIONAL CELL CA
|
|
URETER
|
TRANSITIONAL CELL CA
|
|
BLADDER
|
TRANSITIONAL AND SQUAMOUS CELL
|
|
PROSTATE
|
ADENOCA
|
|
TESTIS
|
GERM CELL
SEMINOMA NON SEMINOMA |
|
URETHRA
|
SQUAMOUS CELL CA
|
|
PENIS
|
SQUAMOUS CELL CA
|
|
GLIAL CELLS
|
ASTOCYTOMA, GLIOBLASTOMA, OLIGODENDROGLIOMA
|
|
DURA/MENINGES
|
MENINGIOMA
|
|
EPENDYMAL CELLS
|
EPENDYMOMA
|
|
EMBRYONAL CELLS
|
MEDULLOBLASTOMA, PNET, GERM CELL TUMOR
|
|
BRAIN METS
|
FROM
LUNG BREAST MELANOMA GI RENAL |
|
RADIOSENSITIVITY CNS
|
FAIR- GLIOMA
GOOD- MEDULLOBLASTOMA, GERM CELL, EPENDYMOMA ARREST OF GROWTH- PITUITARY ADENOMA GOOD- BRAIN METS |
|
SRS
SRT |
STEREOTACTIC RADIOSURGERY
STEREOTACTIC RADIOTHERAPY |
|
RADIOBIOLOGY: INDIRECT ACTION
|
ASSOC WITH XRAYS & GAMMA RAYS
|
|
IONIZATION/ WATER
|
80% OF A CELL IS WATER
HIGH PROBABILITY THAT INTERACTION WITH WATER IONIZATION IS IS THE MEDIUM THAT THE CELL ARE SUSPENDED IN |
|
FREE RADICAL
|
BY PRODUCT OF RAD WITH WATER
-A SINGLE UNPAIRED E- IN THE OUTHER SHELL, CHEMICALLY UNSTABLE |
|
HYDROLYSIS OF WATER
|
PROCESS OF RADIATION ABSORPTION IN WATER
|
|
LET
|
RATE AT WHICH ENERGY IS DEPOSITED A CHARGED PARTICLE TRAVELS THRU MATTER
|
|
LET IS A FUNCTION OF
|
MASS AND CHARGE
|
|
LOW LET
|
XRAYS & GAMMA RAYS, HAVE NO MASS AND NO CHARGE
-SPARSELY IONIZING |
|
HIGH LET
|
PROTONS
NEUTRONS ALPH PARTICLES -B/C THEIR MASS AND CHARGE -DENSELY IONIZING |
|
LET
|
EQUAL DOSES OF LET RADIATIONS DO NOT PRODUCE THE SAME BIOLOGICAL RESPONSE
|
|
RBE
|
COMPARES DIFFERECT TYPES OF RADIATIONS
|
|
RAD/CELL TARGETS
|
MANY PARTS OF THE CELL ARE DUPLICATED THROUGHOUT THE CELL
-DAMAGE TO ONE OR MORE OF THESE MAY NOT BE LETHAL TO THE CELL |
|
CELL MEMBRANE AND DNA
|
ONLY PRESENT IN NECESSARY AMOUNTS
-DAMAGE TO EITHER OF THESE STRUCTURES IS CRITICAL TO THE CELLS ABILITY TO SURVIVE |
|
CELLULAR TARGETS
|
-DAMAGE IN THE DNA CAN BE AND IS REPAIRED IN THE CELL
-ALL TYPES OF DNA DAMAGE ARE NOT EQUAL IN TERMS OF BIOLOGIC SIGNIFICANCE |
|
EFFECTS ON CHROMOSOMES
|
-CAN OCCUR IN BOTH SOMATIC AND GERM CELLS
-CAN BE TRANSMITTED DURING MITOSIS AND MEIOSIS -AS SERIOUS AS DNA DAMAGE |
|
IRRADIATED CELLS 3 POSSIBLE OUTCOMES AFTER IRRADIATION
|
1. DIVISION DELAY- CAN BE DELAYED FROM GOING THRU DIVISION
2. INTERPHASE DEATH- CAN DIE BEFORE IT DIVIDES 3. REPRODUCTIVE FAILURE- CAN DIE WHEN ATTEMPTING MITOSIS |
|
SURVIVAL CURVES- N
|
N- EXTRAPOLATION NUMBER, # OF TARGETS THAT MUST BE HIT IN EACH CELL TO CAUSE DEATH
|
|
SURVIVAL CURVES- Dq
|
QUASITHRESHOLD
WIDTH OF SHOULDER MEASURE OF ABILITY TO REPAIR DAMAGE |
|
SURVIVAL CURVES- Do
|
FINAL OR TERMINAL SLOPE
EXPRESSION OF RADIOSENSITIVITY OF POPULATION |
|
LAW OF B &T
THE MOST RADIOSENSITIVE CELLS WERE THOSE WHICH |
-MOST IMMATURE
-LEAST SPECIALIZED -GREATEST REPRODUCTIVE ACTIVITY -LONGEST MITOTIC PHASE |
|
THE CHEMICAL THAT HAS THE MOST DRAMATIC EFFECT AND HAS UNIVERSALLY BEEN SHOWN TO ENHANCE RAD RESPONSE
|
OXYGEN
|
|
PRESENCE OF OXYGEN
ABSENCE OF OXYGEN |
P- AERATED
A- HYPOXIC |
|
OER (OXYGEN ENHANCEMENT RATIO)
|
MAMMALIAN CELLS IS BETWEEN 2-3
-OXYGEN MOST PRONOUNCED FOR XRAY AND GAMMA RAYS -MUCH LESS FOR HIGH LET |
|
RADIOPROTECTORS
|
GROUP OF CHEMICALS- SULFHYDRYLS
|
|
ACCUTE/CHRONIC EFFECTS
|
ACUTE- DEPLETION OF PARENCHYMA CELLS
CHRONIC- IRREVERSABLE PROGRESSIVE ACUTE CHANGES |
|
HEALING- 2 FORMS
|
1- REGENERATION- REPLACE BY SAME TYPE CELL
2- REPAIR- REPLACE BY DIFF CELL TYPE |
|
ACUTE CHANGES
|
INFLAMMATION
EDEMA HEMORRHAGE DENUDATION OF MUCOSAL SURFACE |
|
CHRONIC CHANGES
|
FIBROSIS
ATROPHY ULCERATION STRICTURE STENOSIS OBSTRUCTION |
|
TBI: BONE MARROW SYNDROME
|
AKA HEMOPOIETIC OR HEMOTOLOGIC SYNDROME
-BTWN 1-10 GY TBI -NO HUMAN CAN SURVIVE TBI >10 GY LD 100 FOR HUMANS IS 10GY |
|
GI SYNDROME
|
6-100 GY
FULL SYNDROME SEEN AT 10 GY |
|
CNS SYNDROME
|
50-100 GY
100 GY TBI DEATH OCCURS 2-3 HRS |
|
WHICH OF THE FOLLOWING ARE RELATIVELY INDEPENDANT OF SOURCE TO SKIN DISTANCE
|
TAR
BSF TMR |
|
THE INVERSE SQUARE LAW IS NOT AN ABSOLUTE CONCEPT FOR
|
E- BEAMS
|
|
THE BEAM INTENSITY OF A CO 60 TELETHERAPY SOURCE HOUSING WITH THE BEAM "ON" IS THE MAX OF
|
1.0 R/HR AT 1 METER
0.1% OF THE USEFUL BEAM AT ONE METER |
|
HIGH RADIATION AREA WARNING SIGNS MUST BE POSTED IN ALL AREAS WHERE A PERSON, IF CONTINUOUSLY PRESENT, COULD RECIEVE AN EXPOSURE IN EXCESS OF ____ MR IN ANY 1 HR
|
100 MR/HR
|
|
THE LEAKAGE LIMITS OF A TELETHERAPY SOURCE HOUSING WITH THE BEAM "OFF" IS A MAX OF ____ AT ANY SINGLE POINT
|
10 MR/HR @ 1 METER
|
|
THE MAX PERMISSIBLE DOSE LIMIT OF EXPOSURE TO THE FOREARM IS
|
50 REM/YR
|
|
THE ____ IS THE DEGREE OF USE OF AN X OR GAMMA RAY SOURCE
|
WORKLOAD
|
|
FOR RADIATION PROTECTION PURPOSES, IT IS USUALLY ASSUMED THAT AN INDIVIDUAL IS AT LEAST ___ INCHES AWAY FROM A PROTECTIVE BARRIER
|
12 INCHES
|
|
THE NORMAL LRG BOWEL TOLERANCE IS APPROX ____ RADS, AND THE SML B TOLERANCE IS APPROX ___ RADS
|
6000- LRG
5000- SML |
|
THE SPINAL CORD TOLERANCE IS APPROX ____ RADS CONSIDERING TX IS GIVEN OVER A 5-6 WK PERIOD
|
45-50 GY
|
|
WIPE TEST ARE USED TO
|
ASSESS LEAKAGE OF BRACHYTHERAPY SOURCES
ASSESS THE AMOUNT OF RADIOACTIVITY LEFT AFTER AND DURING A SPILL |
|
PT WHO HAVE RADIOACTIVE IMPLANTS
|
-PERMANANT IMPLANTS MAY LEAVE WHEN 1 METER DOES NOT EXCEED 5R/YR
-CHILDREN/BABIES 9 FT FROM PT -PRIMARY CARE GIVER OVER 45 YR |
|
A CO 60 SOURCE HAS JUST BEEN REPLACED. WHAT AMOUNT OF RADIOACTIVITY IS THE MOST REASONABLE
|
90 mCi
|
|
WHICH FILTRATION WOULD LLOW FOR THE GREATEST SKIN DOSE
|
**1 MM AL**
1MM CU 2MM AL 2MM CU |
|
A CUTIE PIE IS A TYPE OF
|
IONIZATION CHAMBER
|
|
HAVE THE SAME NUMBER OF PROTONS
|
ISOTOPES
|
|
WHICH IS REPRESENTED BY 13/6 C
|
THE NUCLEUS CONTAINS 7 NEUTRONS
|
|
A 1 MEV PHOTON
|
HAS 1/10 THE WAVELENGHT OF A 100 KEV PHOTON
|
|
WHAT IS EMITTED IN BETA DECAY
|
E-
PHOTON NEUTRINO POSITRON |
|
59 Co 60 Co are
|
ISOTOPES
|
|
THE AVERAGE ENERGY REQUIRED TO REMOVE A NUCLEON FROM A TYPICAL NUCLEUS (BINDING ENERGY) IS
|
8 MEV
|
|
ISOTOPES HAVE THE SAME NUMBER OF
|
PROTONS
|
|
EXAMPLES OF ELECTROMAGNETIC RADIAITON
|
-XRAYS
-RADIOWAVES -VISIBLE LIGHT -RADAR |
|
THE ALPHA PARTICLE IS MOST SIMILAR TO
|
HELIUM NUCLEUS
|
|
KENETIC ENERGY OF CHARGED PARTICLES LIBERATED PER UNIT MASS
|
KERMA
|
|
THE MOST PREDOMINATING RADIATION INTERACTION OCCURING IN MATTER FOR 75 KV SUPERFICIAL BEAM
|
PHOTOELECTRIC
|
|
WHAT IS THE HEAVIEST PART OF AN ATOM
|
NEUTRON
|
|
ONE SIEVERT IS EQUAL TO
|
100 REM
|
|
THE INTERACTION OF XRAYS WITH MATTER THAT IS MOST COMMON IN THE ENERGY RANGE BETWEEN 150 KEV AND 3 MEV IS
|
COMPTON SCATTERING
|
|
GAMMA DECAY
|
-PRECEEDED WITH ALPHA & BETA DECAY
|
|
GAMMA DECAY
|
-PRECEDED BY ALPHA & BETA DECAY
-RESULT IN THE EMISSION OF GAMMA RAYS OF SPECIFIC ENERGIES |
|
AUGER E-
|
-PRODUCED IN SOME NUCLEAR DISINTEGRATION PROCESS
-CAN RESULT FROM E- CAPTURE - HAVE REST MASS OF 0.511 MEV |
|
FACTORS THAT INFLUENCE THE OUTPUT OF AN XRAY UNIT
|
FILTRATION
MA FIELD SIZE DISTANCE |
|
WHY SHOULD YOU NOT ENTER THE TX ROOM IMMEDIATELY FOLLOWING AN 18MV TX
|
BECAUSE OF NEUTRON CONTAMINATION
|
|
THE QUANTITY THAT AN IONIZATION CHAMBER USUALLY MEASURES IS
|
KERMA
|
|
THE UNIT OF ABSORBED DOSE IS
|
JOULE
GRAY RAD |
|
REGARDING STOCHASTIC EFFECTS
|
THE EFFECTS CAN BE ON THE INDIVIDUAL EXPOSED
THE SERVERITY OF THE EFFECT IS RELATED TO DOSE |
|
EX OF A NON STOCHASTIC EFFECT
|
CATARACTS
|
|
DOSE EQUIVILANT IS
|
EQUAL TO THE QUALITY FACTOR MULTIPLIED BY THE ABSORBED DOSE
MEASURED IN REM SV |
|
EMBRYO/FETUS WILL HAVE SEVERVE ABNORMALITIES WHEN IRRADIATED
|
4-11 WKS
|
|
AVE SURVIVAL TIME FOR GI SYNDROME
|
3-10 DAYS
|
|
WHERE IS BENDING MAGNET FOUND
|
GANTRY HEAD
|
|
PRIMARY RADIATION PRODUCED BY AN XRAY MACHINE INCLUDES
|
CHARACTERISTIC
BREMSSTRAHLUNG |
|
TEST WITH FILM SHIELD BY 2 LEAD BLOCKS EXPOSED AT 180* APART IS
|
SPLIT FIELD TEST
|
|
RECOMMENDED THAT THE FETUS SHOULD NOT EXCEED
|
.5 REM (.005 SV)
|
|
THE EFFECTIVE ANNUAL DOSE, WHOLE BODY TO RAD WORKER
|
5,000 MREM (50 SV)
|
|
THE PRINCIPLE OBJ FOR FIELD SYMMETRY AND FLATNESS IS TO DETERMINE
|
DOSE RATE CONSISTENCY ACROSS FIELD
|
|
A COMMON CAUSE OF A LONGITUDINAL SHIFT BETWEEN RADIATION FIELDS DURING A SPLIT FIELD TEST IS INCORRECT WEDGE PLACEMENT
|
SAGGING GANTRY ARM
|
|
EMERGENCY BUTTONS SHOULD BE CHECKED
|
MONTHLY
|
|
TEST IF DOSE IS EQUAL ON EITHER SIDE OF THE CENTRAL AXIS
|
SYMMETRY
|
|
REQ ON PERSONNEL MONITORING REPORT
|
BIRTH DATE
CUMULATIVE LIFETIME EXPOSURE |
|
NCRP 91 RECOMMEND DOSE LIMITS: TOTAL BODY ANNUALLY
|
5 REM
50 MSV |
|
NCRP 91 RECOMMEND DOSE LIMITS: LENSE OF EYE ANNUAL
|
150 MSV
|
|
NCRP 91 RECOMMEND DOSE LIMITS: SKIN ANNUAL
|
500 MSV
|
|
MISADMIN IN XRT
|
WRONG PT
TOTAL DOSE OVER 20% WEEKLY DOSE OVER 30% E- BEAM INSTEAD OF PHOTON |
|
VISITORS OF BRACHY PT
|
20 MIN/DAY
|
|
AFTER INJECTION IODINE 131 WHERE DISPOSE SYRINGE
|
SEND TO MANUFACTURER
|
|
SELLA TURSICA IS A DEPRESSION OF
|
SHENOID
|
|
C VERTEBREA WITH NO BODY OR SPINOUS
|
FIRST
C1 |
|
WALDEYER'S RING IS A GROUP OF LYMPHOIOD ORGANS CONSISTING OF
|
PALATINE T
LINGUAL T NASOPHARYNGEAL TONSILS |
|
HYPOPYSIS OTHER NAME IS
|
PITUATARY
|
|
LYMPHATIC DUCT OPENS INTO THE BLOOD STREAM AT THE JUNCTIONS OF THE RT SUBCLAVIAN VEIN WITH THE ____ VEIN
|
INTERNAL JUGULAR
|
|
MOST COMMON SITE OF BREAST CA
|
UPPER OUTER QUAD
|
|
STENSONS DUCT IS LOCATED IN THE
|
PAROTID
|
|
VIRCHOWS NODES OTHER NAME
|
LEFT SUPRACLAV NODE
|
|
MITOSIS ORDER
|
INTERPHASE
PROPHASE METAPHASE ANAPHASE TELOPHASE |
|
OXYGENATED BLOOD RETURNS FROM THE LUNG VIA THE ______ AND ENTERS THE _____ OF THE HEART
|
PULMONARY VEIN
LEFT ATRIUM |
|
PEYERS PATCHES FOUND IN
|
SML INTESTINES
|
|
A BLAST CELL
|
LEAST DIFFERENTIATED BLOOD CELL
IMMATURE STEM CELL |
|
THE BRACHIAL PLEXUS LOCATED
|
LOWER CERVICAL
UPPER CHEST |
|
ANGLED FORMED BETWEEN DIAPHRAGM AND RIBS
|
COSTOPHRENIC
|
|
DIRECT LYMPH DRAIN FOR VULVA
|
SUPERFICIAL INGUINAL
|
|
NOT FOUND IN LYMPH FLUID
|
PLATELETS
RBC'S |
|
LYMPH OF THE TONGUE DRAIN TO
|
JUGULAR
|
|
BIFURCATION OF AORTA AT WHAT VERT LEVEL
|
L4-L5
|
|
ANGLE OF LOUIS IS A LANDMARK FOR
|
BREAST
|
|
PANCOAST SYNDROME ASSOCIATED W/
|
LESIONS IN THE APEX LUNG
BRACHIAL PLEXUS INVOLVEMENT ARM WEAKNESS |
|
PRIMARY PRESENTING SYMPTOM OF BLADDER CA
|
HEMATURIA
|
|
MOST COMMON PATH FOR ANAL TUMORS
|
SQUAMOUS CELL
|
|
RISK FACTORS FOR COLORECTAL CA
|
1ST DEGREE RELATIVE
CHRONIC ULCERATIVE COLITIS GARDNERS SYNDROME |
|
DIET INCREASE INCIDENCE OF COLORECTAL CA
|
HIGH ANIMAL FAT
HIGH FRUITS VEGGS LOW IN FIBER |
|
CHEMO MOST USED FOR GI
|
5FU
|
|
STAGING SYSTEM FOR CERVICAL CA
|
FIGO
|
|
SYMPTOMS COMMON IN CA OF NASOPHARYNX
|
LUMP IN NECK
DIFFICULTY HEARING STUFFY NOSE |
|
SMALL ORAL CAVITY LESIONS ARE TX
|
SURGERY
|
|
MOST COMMON PATH FOR THYROID CA
|
PAPILLARY
|
|
EARLY LESION OF TRUE VOCAL CORDS
|
RARELY MET TO ANY LYMPH NODES
|
|
CELL ASSOCIATED WITH HODGKINS
|
REED STERNBERG CELL
|
|
SCREENING FOR BRST CA INCLUDE
|
MONTHLY SELF EXAM AFTER 20YR
CLINICAL BREAST EXAM EVERY 3 YRS AFTER 20 |
|
GLEASON SCORE FOR PROSTATE CA INDICATES
|
HISTOLOGIC GRADE OF TUMOR
|
|
SCREENING METHOD FOR PROSTATE CA HAS HIGHEST SENSITIVIEY IN DETECTION OF THE PROSTATE
|
TRUS
|
|
FOR XRT OF UP ABD FOR PANCREATIC CA, MOST RADIOSENSITIVE DOSE LIMIT STRUCTURE
|
SPINAL CORD
|
|
45 YR OLD WOMEN
DISCOMFORT 6 MO 3 MO SKIRTS DONT FIT NO SIGNIFICANT WEIGHT GAIN PROBLEM? |
OVARIAN CA
|
|
AS KVP INCREASES SCATTER RAD WILL
|
INCREASE BECAUSE OF MORE COMPTON INTERACTION
|
|
AN INCREASE IN KVP RESULTS IN
|
AN INCREASE IN QUANTITY
|
|
CONTRAST FOR ILIAC ARTERIES
|
IV CONTRAST
|
|
REDUCES VISCOSITY OF AN IV CONTRAST AGENT
|
WARMING
|
|
DAILY QA FOR CT SIM
|
LASER POSITION VERIFICATION
E- DENSITY VERIFICATION WATER PHANTOM SCAN |
|
INCREASE IMAGE MATRIX WITH SAME FIELD OF VIEW WILL
|
INCREASE RESOLUTION
|
|
INPUT PHOSPHOR ON AN IMAGE INTENSIFIER CONVERTS
|
XRAYS TO LIGHT
|
|
COMMON ILIAC NODES BIFRICATE AT
|
S2`
|
|
ESOPHAGUS BEGINS AT LEVEL
|
C6
|
|
POINT "A"
|
2 CM SUP AND 2 CM LAT FROM EXT OS
URETER CROSSES UTERINE ARTERY |
|
RAD THERAPY TECHN FOR ENDOMETRIAL CA WITH RADIOACTIVIE SOURCES CARRIED IN METAL CAPSULES AND PACKED INTO UTERUS
|
FLETCHER SUIT
|
|
TYPICAL LUNG FIELD DOSE/TX
|
AP/PA TO 3960 OBL TO 6000
|
|
TRANSMISSION THRU LEAD BLOCK SHOULD BE
|
NO MORE THAN 5%
|
|
WEDGE ANGLE REFERS TO
|
ANGLE WHICH ISODOSE CURVE AT SPECIFIC DEPTH IS TILTED WITH RESPECT TO CENTRAL AXIS OF BEAM
|
|
TD 5/5 TESTIS
|
100 CGY
|
|
FOR MANTLE XRT, PT ARMS ABOVE HEAD WHY
|
MOVES AXILLARY NODES AWAY FROM CHEST WALL
|
|
PITUATARY FOSSA LOCATED BY
|
2 CM ANT AND 2 CM SUP TO EAM
|
|
COMMON VALUE FOR FIELD FLATNESS OVER THE CENTRAL 80% OF THE LRGST FIELD SIZE AT ISOCENTER
|
+-3%
|
|
INTEGRAL DOSE
|
IS A MEASURE OF THE TOTAL ENERGY DEPOSITED IN THE PT
|
|
CHANGING THE TFD ACCOMPLISHED BY
|
MOVING THE COUCH
|
|
TD 5/5 FOR 3/3 OF ESOPHAGUS
|
5500
|
|
ONLY "R" THAT SELECTIVELY INCREASES TUMOR CELL KILL AND ITS ABSENCE IS RESPONSILBLE FOR TUMOR RECURRENCE
|
REOXYGENATION
|
|
INCREASES GEOMETRIC PENUMBRA
|
INCREASE SOURCE SIZE
DECREASE SOURCE-COLLIMATOR DIST INCREASE SOURCE-CALCULATION DIST (SSD+D) |
|
DENSITY ON A CT SCANNER WHERE PIXEL IS ASSIGNED VALUE
|
HOUNSFIELD UNIT
|
|
CONTOUR OF PT SHOULD INCLUDE WHAT INFO
|
PTV
CENRAL AXIS DOSE LIMITING STRUCTURES |
|
THE EFFECT OF TISSUE INHOMOGENEOUS ON DOSE DEPENDS UPON
|
BEAM ENERGY
VOL OF INHOMOGENEITY TISSUE DENSITY |
|
DOCUMENTED DURING SIM
|
FIELD SIZE
PT POSITION |
|
WHEN SECTOR IS SKIPPED IN ARC THERAPY
|
HIGH DOSE AREA IS SHIFTED AWAY FROM HE SKIPPED SECTOR
|
|
WIDTH OF PENUMBRA INCREASES WITH`
|
INCREASED SSD
DECREASED SOURCE-COLLIMATOR DIST INCREASED SOURCE SIZE |
|
A LESION TREATED USING 100* ARC ROTATION, MIDPT OF TUMOR 5 CM. ISOCENTER SHOULD BE PLACED AT
|
7.5 CM
|
|
WHAT INFO NEEDED FOR FABRICATING DIVERGENT BLOCKS
|
MACHINE TAD, TFD, TTD
|
|
THE USE OF BOLUS
|
COMPENSATES FOR SURFACE IRREGUALARITIES
INCREASES THE SKIN DOSE BY ELIMINATING SKIN SPARRING |
|
LEGAL DOCTRINE OF BORROWED SERVANT REFERS
|
DR OVERSEEING THE R.R. MAY BE HELD RESPONSIBLE FOR THE RT'S ACTIONS
|
|
WHAT LEVEL AN IV BAG HANG ABOVE IV SITE
|
18''-24"
|
|
CPR COMPRESSIONS TO BREATHS
|
15 COMPRESSIONS TO 2 BREATHS
|
|
WHEN PT SHOWS SIGNS OF SHOCK
|
KEEP PT CALM AND MAINTAIN NORMAL BODY TEMP
|
|
PURPOSE OF ASRT CODE OF ETHICS
|
ASSIST TECHS IN MAINTAING HIGH LEVEL OF ETHICAL CONDUCT
|
|
MOST COMMON MEANS INFECTIONS TO SPREAD
|
DIRECT CONTACT
|
|
PT W/ URINARY CATHETERS, DRAIN BAG SHOULD BE LOWER THAN BLADDER TO
|
PREVENT INFECTION
|
|
METHODS OF STERILIZATION
|
DRY HEAT
AUTOCLAVE CHEMICALS GAS |
|
HEMOPTYSIS MEANS
|
BLOOD IN SPUTUM
|
|
MOST IMPORTANT SIDE EFFECT FOR HODGKINS PT WITH XRT
|
DEPRESSION OF BONE MARROW
|
|
CARDIAC TOXITICIY FROM BREAST XRT
|
SOMETIMES A SERIOUS PROBLEM
|
|
XRT OF SALIVARY GLANDS MAY RESULT IN
|
DENTAL CARIES
GINGIVITIS CHANGE OF ORAL BACTERIA |
|
SHOCK WHERE MASSIVE BUILD UP OF BACTERIA AND TOXIC BY PRODUCTS
|
SEPTIC SHOCK
|
|
FOR XRT OF GI AND CAUSING DIARRHEA, DIET SHOULD BE
|
LOW RESIDUE DIET
INCREASED LIQUIDS DECREASE LACTOSE DECREASE EXERCISE |
|
SWEATING, ANXIETY AND TACHYCARDIA ASSOCIATED WITH THE EXCESS PRODUC OF INSULIN BY ISLET CELL PANCREATIC CA MOSTLY DUE TO
|
HYPOGLYCEMIA
|
|
PARENTERAL HYPERALIMENTATION CAN BE ADMINISTERED VIA
|
IV
|
|
LEAST LIKELY TO AFFECT ISODOSE CURVES
|
BOLUS**
(WEDGE, COMPENSATOR) |
|
POINT -30MM ON Y-AXIX ON AP SUPINE PT. REFERENCE POINT IS
|
3 CM INF
|
|
GANTRY ROTATES AROUND HORIZON AXIS WHICH IS
|
PARALLEL TO NORMAL COUCH POSITION
|
|
THICKNESS OF LEAD CUTOUT NEEDED FOR 10 MEV E-
|
5 MM
|
|
COMPENSATING FILTERS USED TO
|
COMPENSATE FOR IRREGULAR SURFACE
|
|
PERSCRIPTION SHOULD INCLUDE
|
TX TECHN
ANATOMICAL SITE FRACTIONATION PROTRACTION |
|
ACCEPTABLE STORAGE FOR FILM
|
16* C AND 10% HUMIDITY
|
|
CONSIDERED ARTIFACT
|
PRESSURE MARK
|
|
IN PORT FILMS OF POP ISOCENTRIC FIELDS OF LUNG TUMOR THE
|
ANT PORTAL WILL APPEAR TO TREAT MORE SPINE
|
|
ALPHA PARTICLES
|
COMPOSED OF 2P & 2N
|
|
1 CURIE IS EQUAL TO __ Bq
|
3.7 X 10 10
|
|
AVERG ENERGY DEPOSITED PER UNIT PATH LENGTH TO A MEDIUM BY IONIZING RAD AS IT PASSES THRU THAT MEDIUM IS
|
LET
|
|
RADIAITONS THAT DEPEND LEAST ON THE AMOUNT OF OXYGEN IN THE CELL
|
NEUTRONS
ALPHA PARTICLES |
|
DESCRIBES TERMINAL SLOPE PORTION OF THE CELL SURVIVAL CURVE
|
Do
|
|
PROPERTY OF XRAY EFFECT ON BIOLOGICAL SYSTEMS IS THAT THEY
|
CAUSE IONIZATION IN MATTER
|
|
CELLS IN THE BODY THAT IS MOST RADIOSENSITIVE
|
LYMPHOCYTES
|
|
EXPOSURE IS
|
IONIZATION IN AIR
AMOUNT OF CHARGE PER UNIT MASS MEASURED USING IONIZATION CHAMBER |
|
SHORT TERM SOMATIC EFFECTS OF RAD
|
NAUSE
FATIGUE BLOOD AND INTESTINAL DISORDERS DIFFUSED REDNESS OF SKIN AND SHEDDING OUTER LAYER |
|
FOLLOWS SIGMOID DOSE-RESPONSE CURVE
|
CATARACTS
SKIN ERYTHEMA |
|
NEUTRON CONTAMINATION AS A RESULT OF PHOTON INTERACTION WITH HIGH Z MATERIALS
|
PHOTODISINTEGRATION
|
|
PHASE WHERE CHROMATIDS REPEL EACH OTHER AND MIGRATE ALONG SPINDLE TO OPP POLES
|
ANAPHASE
|
|
IN CELL CYCLE Go REFERS TO
|
A NON DIVIDING CELL
|
|
BLOOD CELLS FROM MOST RAD SENSITIVE TO LEAST
|
LYMPHOCYTES
NEUTROPHILS PLATELETS RBC |
|
IN STOCHASTIC EFFECTS
|
DOSE AND PROBABILITY ARE DIRECTLY RELATED
NO THRESHOLD CAUSE SIMILAR DISEASES SEEN IN UNIRRADIATED POPS |
|
AN INCIDENT XRAY INTERACTS AND IONIZES AN INNER SHELL E- AND EJECTS AN E-, IS
|
PHOTOELECTRIC ABSORPTION
|
|
INELASTIC INTERACTION IS THE IONIZATION OF AN FREE E- AND RESULTS IN SCATTERED XRAY
|
COMPTON SCATTER
|
|
WHEN TREATING WITH E- BEAMS, WHAT MOVES OFF AXIS
|
TARGET AND FLATTENING FILTER
|
|
DURING EXTERNAL BEAM, COLLIMATOR AND OR ANY LEAD BLOCKS AT MIN DIST, WHY
|
REDUCE E- CONTAMINATION
|
|
TO PROPERLY CALIBRATE ION CHAMBERS, TEMP AND PRESSURE
|
0*C -760 MMHG
|
|
FIRST NOTICABLE REACTION TO TBI TO SUBLETHAL DOSE
|
LEUKOPENIA
|
|
PROTECTIVE SOURCE HOUSING OF A GAMMA-BEAM MACHINE, IN "ON" POSITION, MUST BE THICK ENOUGH ABLE TO REDUCE BEAM INTENSITY TO AN AMOUNT LESS THAN
|
O.1% OF THE USEFUL BEAM AT 1 METER
|
|
SUPERFICIAL XRAY THERAPY UNITS OPERATE AT
|
50-120 KVP
|
|
IN LINAC, CATHODE IS ANALOGOUS TO
|
THE ELECTRON GUN
|
|
MECHANICAL DIST INDICATORS CAN BE EMPLOYED TO VERIFY
|
ACURACY OF OPTICAL DIST
|
|
THE POINT OF MAX BUILD UP OF CESIUM UNIT IS
|
0.1 MM
|
|
LET IS MEASURED IN
|
KEV/MICRON
|
|
WHICH IS NOT NEEDED IN CONSTRUCTING LOW MELTING ALLOW SHIELDING BLOCKS
|
SOURCE TO SKIN DIST
|
|
WHAT THICKNESS OF LEAD IS EQUIV TO 7.5 CM OF CERROBEND
|
6 CM
|
|
BEST TECH TO TX NON MIDLINE PRIMARY BRAIN
|
WEDGE PAIR
|
|
WHEN TX OF TANG BRST, NO MORE THAN ____ OF LUNG
|
3 CM
|
|
CHILD TX WITH CRANIOSPINAL, THE POST SPINAL FIELD SELDOM EMPLOYS PHOTONS. WHY?
|
EXIT DOSE WOULD IRRADIATE MEDIASTINUM, STERNUM, AND THYROID
|
|
WHEN TX EWINGS TUMOR WITH XRT
|
IF TUMOR IS MID BONE, BOTH EPIPHYSEAL PLATES RADIATED
AVOID THE ENTIRE LIMB FOR LYMPH DRAIN |
|
WHEN IS FETUS MOST SENSITIVE
|
1ST TRIMESTER
|
|
CONGENITAL ABNORMALITIES INCREASE WHEN IRRADIATED DURING
|
MAJOR ORGANGENESIS OR
10TH TO 6TH WK @ .25 GY |
|
RADIATION DURING FETAL GROWTH STAGE OR AFTER 6TH WK
|
INCREASED CA LATER IN LIFE
|
|
RADIATION IN CONCEPTION TO 10TH DAY OR PRE-IMPLATATION PHASE IS EITHER
|
LETHAL OR FETUS SHOWS NO EFFECT
|
|
LATE EFFECTS
|
MANIFEST AFTER LONG PERIODS OF TIME
REMAIN DORMANT FOR YRS MAY SHOW UP IN SUCCEEDING GENERATIONS |
|
LATE EFFECT ARE EITHER
NONSTOCHASTIC OR STOCHASTIC |
NON STOCHASITC- HAS THRESHOLD
EFFECT IS DOSE RELATED (CATERACTS) STOCHASITIC: NO THRESHOLD ANY DOSE, NO MATTER HOW SMALL CARRIES PROBABILITY (CXR CAUSING DNA BREAK) |
|
CARCINOGENESIS IS THE SINGLE IMPORTANT ______ INDUCED BY RADIATION
|
LATE SOMATIC EFFECT
|
|
SOMATIC EFFECTS
|
BODY CELLS
|
|
GENETIC EFFECTS
|
REPRODUCTIVE CELLS
|
|
MUTENGENS
|
FREQ OF SPONTANEOUS MUTATIONS CAN BE ALTERED BY VIRUSES, CHEMICALS AND RADIAITON.
PERMANANT AND INHERITABLE |
|
4 R'S OF FRACTIONATED RADIOTHERAPY
|
REDISTRIBUTION
REOXYGENATION REGENERATION REPAIR |
|
REDISTRIBUTION
|
IN FX SCHED
RESULT IN CELL KILL IN TUMORS AND ACUTELY RESPONDING NORMAL TISSUES. BUT NO EFFECT ON LATE RESPONDING NORMAL TISSUES |
|
MOST SENSITIVE PHASES
|
M AND G2
|
|
MOST RESISTANT PHASES
|
S
|
|
REOXYGENATION
|
HYPOXIC CELLS ARE 3X MORE RESISTENT THAN OXYGENATED CELLS
|
|
R THAT SELECTIVELY INCREASES TUMOR CELL KILL
|
REOXYGENATION
|
|
REGENERATION
|
OCCURS IN TUMOR AND ACUTELY RESPONDING TISSUES
|
|
REPAIR
|
REFERS TO CELLULAR REPAIR OF RAD DAMAGE
BIGGEST ROLE IN SPARING EFFECT OF FX., B/C IN BOTH NORMAL AND ACUTELY AND LATE RESPONDING , AND TUMORS |
|
IRRADIATION DISTURBS MITOTIC INDEX BY
|
DIVISION DELAY
|
|
IN DIVISION DELAY CELLS BECOME DELAYED IN WHAT PHASE
|
G2
|
|
CELL LINE THAT DOES NOT FIT THE B&T MODEL OF RADIOSENSITIVITY
|
LYMPHOCYTES
|
|
OER FOR MAMMALS HAS BEEN SHOWN TO BE BETWEEN
|
2 & 3
|
|
ALTHOUGH LUNGS DO NOT CONTAIN STEM CELLS, THEY ARE RADIOSENSITIVE, AND CHANGES SEEN AT
|
20GY
|
|
LD 50/30 FOR HUMANS IS
|
2.5 AND 3.0 GY
|
|
PRE-IMPLANTATION IS
|
CONCEPTION TO DAY 10
|
|
CONDITIONS THAT NEED TO BE MET FOR RAD SYNDROME TO OCCUR
|
EXPOSURE ACUTE (IN MIN)
TOTAL OR NEAR TOTAL EXTERNAL SOURCE RAD |
|
BASED ON ATOMIC BOMB SURVIVORS, GEN DBLING DOSE IS
|
156 REM
|
|
NOT CONSIDERED MUTAGENIC
|
BACTERIA
|
|
SHOULDER OF CELL SURVIVAL CURVE IS
|
THE REPAIR CAPACITY OF THE CELL
|
|
TERMINAL EXPONENTIAL PORTION OF CELL CURVE IS EQUAL TO
|
37%
|
|
LAW OF B&T, WHAT CELLS MOST RADIOSENSITIVE
|
GREATEST REPRODUCTIVE ACTIVITY
|
|
OYGEN WORK IN 3 WAYS
|
ENHANCMENT OF FREE RADICAL FORMATION
REPAIR CAPABILITIES OF CELL BLOCKED FIXES THE DAMAGE THUS MAKING IT PERMINANT |
|
ACUT DOSE OF RAD THAT INDUCES 100% OF POP
|
2 GY
|
|
DOSES AS LOW AS ___ IN FETUS CAUSES MALIGNANCIES IN ADULTS
|
.25 GY
|
|
NON STOCHASTIC EFFECTS
|
DERTERMINISTIC
INCREASE DOSE, INCREASE SEVERITY CATERACTS EX |
|
PERM STERILITY IN WOMEN AND TEMP IN MEN SEEN WHAT DOSES
|
W- 6.25 GY
M- 2.5 GY |
|
DOSE OF ___ FATAL DURING PRE-IMPLANTATION PHASE
|
.1 GY
|
|
LD 100 FOR HUMANS
|
10 GY
|
|
LATENT PERIOD ASSOCIATED WITH SOLID TUMORS
|
20-30 YRS
|
|
PROCESS BY WHICH BROKEN ENDS OF CHROMOSOMES REJOIN WITH NO DAMAGE IS
|
RESTITUTION
|
|
FIRST INTERACTION IN THE HYDROLYSIS OF WATER
|
IONIZATION OF WATER MOLECULE
|
|
NEUTRONS HAVE DIFF EFFECT ON WHAT PART OF SURVIVAL CURVE
|
SHOULDER
|
|
MOST SENSITIVE PHASE OF CELL CYCLE
|
M
|
|
LEAST SENSITIVE PHASE
|
S
|
|
WHEN PRESENT, PROTECTION FACTOR FOR RADIOPROTECTORS IS
|
2 TIMES DOSE
|
|
MOST RADIOSENSITIVE IN GI
|
SML BOWEL
|
|
ONLY CA TO FOLLOW LINEAR RELATIONSHIP DOSE
|
BREAST
|
|
TD 5/5 FOR KIDNEY
|
23 GY
|
|
TD 5/5 BRAIN
|
45 GY
|
|
TD 5/5 LIVER
|
45 GY
|
|
TD 5/5 RECTUM
|
60 GY
|
|
TD 5/5 STOMACH
|
50 GY
|
|
R- THAT HAS 5X SURVIVAL BTWN MOST RESISTANT AND MOST SENSITIVE PHASE
|
REDISTRIBUTION
|
|
RIGHT AFTER XRT MOST CELLS IN TUMOR ARE HYPOXIC
|
REOXYGENATION
|
|
WITH OUT THIS R, WOULD NOT BE ABLE TO CURE ANY TUMOR
|
REOXYGENATION
|
|
2 R'S APPLY TO ACUTELY OR RAPIDLY DIVIDING TUMOR TISSUE
|
REDISTRIBUTION
REGENERATION |
|
ONLY R THAT SELECTIVELY INCREASES TUMOR CELL KILL
|
REOXYGENATION
|
|
REFER TO ABILITY OF CELL TO UNDERGO SLDR AND PLDR
SUBLETHAL DAM REPAIR POTENTIALLY LETHAL DR |
REPAIR
|
|
PLAYS BIGGEST ROLE IN SPARING EFFECT IN FX
|
REPAIR
|
|
FEDERAL ANGENCY RESPONSIBLE FOR REACTOR PRODUCED ISOTOPES
|
NRC
|
|
WHO LICENSE RADIUM
|
STATE RADIATION CONTROL AGENCY
|
|
DIRECT EFFECT DEPENDS ON OXYGEN. T/F
|
FALSE, DIRECT EFFECTS ARE DENSELY IONIZING
|
|
WHERE ARE E- SCATTERING FOILS LOCATED
|
HEAD OF LINAC
|
|
AVG BODY TEMP
|
98.6*F OR 37*C
|
|
AVG PULSE RATE
|
60-90 BEATS/MIN
|
|
AVG RESPIRATIONS
|
10-20 BREATHS/MIN
|
|
SYSTOLIC (TOP NUMBER)
DIASTOLIC (BOTTOM NUMB) |
110-140 MM HG (ADULT)
60-80 MM HG |
|
AN AP FILM OF THE PELVIS IS GOOD FOR INTERPRETATION OF ALL EXCEPT
|
ANT/POST
|
|
PERSON MOVES IN CT SIM, WHAT HAPPENS
|
MOTION, MUST REPEAT
|
|
WHAT IS A HAZARD IN CERROBEND
|
BLTC
BISMOUTH LEAD TIN CADMIUM |
|
PT IMMUNOSURPRESSED, ISOLATION?
|
REVERSE OR PROTECTIVE ISOLATION
|
|
VISUAL GOES DOWN DURING TX
|
STOP
|
|
WHY DO YOU ANGLE FOR SUPRACLAV?
|
GET OFF CORD
10-15* |
|
WHAT ARISES IN MESENCYMAL CELLS
|
SARCOMAS
|
|
ENDOMETRIAL CA IS WHAT HISTOLOGY
|
ADENO CA
|
|
WHAT HISTOLOGY IS PROSTATE CA?
|
ADENO CA
|
|
LEIOMYOSARCOMA ARISE FROM
|
SMOOTH
|
|
RHABDOMYO
|
STRIATED
|
|
WHAT STRUCTURES ARE OF CONCERN WHEN TX PANCREAS
|
C LOOP OF DUEDENUM
CORD KIDNEY SML BOWEL |
|
CRITICAL STRUCTURES OF ADB
|
KIDNEY
LIVER SML |
|
WHEN IS CONSENT SIGNED
|
BEFORE, DURING CONSULT
|
|
WILM TUMOR PRESENTS AS
|
PAINLESS MASS
|
|
KVP RANG FOR CT
|
120-140 KVP
|
|
WHERE COULD PT DIE OF INFECTION
|
GI
NOT: BM OR CNS |
|
CHARGE FOR 3D CONFORMAL TX
|
COMPLEX, BECAUSE CT
|
|
MOST SENSITIVE PERIOD FOR FETUS
|
1ST TRIMESTER
1-3 MO |
|
DIET FOR OVERWEIGHT ESOPHAGEAL CA
|
PROTEIN
NO SPICES BLAND DIET NO ALCOHOL |
|
BEST WAY TO TX ESOPHAGUS
|
OBL TO STAY OFF CHORD
|
|
BEST WAY TO TX EXTREMITIES
|
AP/PA, BUT LEAVING STRIP FOR LYMPH DRAIN
|
|
MOST COMMON SKIN CA
|
BASAL CELL
|
|
CAUSES OF WEDGE FAULT
|
WEDGE NOT IN ALL THE WAY
WRONG WEDGE |
|
WHAT CAUSES METS TO PROSTATE
|
ADV STAGES
|
|
SIMPLE TX DEVICES
|
-SIMPLE BLOCK (SQ, RECTANG, CIRCLES)
-BOLUS -PASSIVE, MULTI-USE DEVICE (RESTRAINTS, PILLOWS, STRAPS, WINGBOARD) |
|
INTERMEDIATE TX DEVICES
|
-BLOCKS- (STANDARD, NOT CUSTOMED TO PT)
-STENTS -BITE BLOCKS -SPECIAL BOLUS- CUSTOM |
|
COMPLEX TX DEVICE
|
-BLOCKS- CUSTOM
-IMMOBILATION DEVICE- VAC LOCKS -WEDGES -COMPENSATORS -EYE SHIELDS |
|
SPEED OF LIGHT
|
3X10^8
|
|
PHOTONS
|
-NO MASS
-NO CHARGE -PACKETS OF ENERGY IN STRAIGH LINE |
|
AMPLITUDE IS ___ OF THE WAVE
|
HEIGHT
|
|
WAVELENGTH IS
|
CREST TO CREST
|
|
VELOCITY IS
|
WAVELENGTH X FREQ
|
|
ENERGY=
|
PLANKS CONSTANT
4.15 X 10^15 EV X FREQ` |
|
DIFFERENCE BTWN GAMMA AND PHOTON
|
GAMMA COMES FROM NUCLEUS
PHOTON COMES FROM ORBITING E- |
|
XRAYS DISCOVERED BY AND WHEN
|
WILLIAM ROENTGEN
NOV. 11, 1895 |
|
DIAGNOSTIC XRAYS
|
50-120 KVP RANGE
|
|
THERAPEUTIC XRAYS
|
40-300 KVP
|
|
CATHODE
|
NEGATIVE (-)
2 PARTS: FILAMENT & FOCUSING CUP |
|
FILAMENT
|
SML COIL OF THORIATED TUNGSEN WIRE
|
|
FOCUSING CUP
|
NEGATIVE CHARGE DIRECTS E- TOWARD ANODE
|
|
ANODE
|
POSITIVE (+)
TARGET RECIEVES E- FROM CATHODE |
|
POTENTIAL DIFFERENCE
|
KVP
|
|
TARGET INTERACTIONS
|
BREMSTRAHLUNG AND CHARACTERISTIC
|
|
XRAY INTERACTIONS WITH MATTER
|
ATTENUATION
COMPTON SCATTERING PHOTOELECTRIC |
|
MATTER CAN NEITHER CREATED OR DESTROYED
|
IT CAN ONLY CHANGE STATE
|
|
FILM 3 COMPONENTS
|
BASE
EMULSION PROTECTIVE COAT |
|
MITOSIS
|
CELL DIVISION
OUTCOME 2 IDENTICAL DAUGHTER CELLS |
|
MITOSIS PHASES
|
G0, G1, S, G2, AND M
|
|
G0
|
CELLS FULLY FUNCTIONING AND NOT PREPARING FOR DUPLICATION
|
|
G1
|
1ST GROWTH PHASE, RAPID GROWTH
SYNTHESIZES RNA |
|
S
|
SYNTHESIS:
DNA IS REPLICATED ENSURING DAUGHTER WILL HAVE IDENTICAL GENETIC MATERIAL |
|
G2
|
CELL PREPARES FOR DIVISION
|
|
M
|
MITOSIS OR CELL DIVISION
|
|
WELL DIFFERENTIATED
|
CLOSELY RESEMBLE CELL ORIGIN
|
|
UNDIFFERENTIATED
|
(ANAPLASTIC)
DO NOT RESEMBLE ORIGIN |
|
BENIGN
|
(NON CANCER)
GROW SLOW, WELL DIFFER NO DISTANT SPREAD |
|
METS
|
SPREAD TO OTHER PARTS OF BODY
|
|
SARCOMAS
|
TUMORS FROM MESENCHYMAL CELLS LIKE BONE AND CARTILAGE
|
|
CARCINOMAS
|
TUMORS FROM EPITHELIUM CELLS (COVER OF LINE CAVITY)
|
|
ADENCOCARCINOMAS
|
TUMORS FROM GLANDS (PROSTATE)
|
|
BODY CELLS (SOMATIC CELLS) REPRODUCE BY____
REPRODUCTION OF GAMETES OR SEX CELLS BY _____ |
BODY CELLS- MITOSIS
SEX CELLS- MEOSIS |
|
INTERPHASE
|
RESTING PHASE
|
|
PROPHASE
|
DNA DBLED
CHROMOSOME PAIRS DUPLICATE TO FORM TWICE THE NORMAL DIPLOID |
|
METAPHASE
|
CHROMOSOMES LINE UP IN THE CENTER AND ATTACHED TO THE SPINDLE THREADS
|
|
ANAPHASE
|
SEPARATION OF THE CHROMOSOME PAIR
|
|
TELOPHASE
|
ALL CHROMOSOMES BEGIN TO UNCOIL AND LENGTHEN.
DIVIDES INTO 2 EQUAL PORTIONS, 46 CHROMOSOMES |
|
VICTOREEN CONDENSER R METER
|
GAS FILLED TO CALIBRATE XRAY EQUIP
MOST COMMONLY USED |
|
PRIMARY BARRIERS
|
GENERALLY LINED WITH LEAD
1.6 MM OR 1/16TH IN. THICK |
|
SECONDARY BARRIERS
|
.8 MM OR 1/32TH IN. THICK
|
|
RULE OF THUMB FOR RADIOACTIVE WASTE
|
LET DECAY FOR 10 HALF-LIVES
|
|
MOST COMMON BRAIN PRIMARY
|
ASTROCYTOMA
|
|
GLIOBLASTOMA MULTIFORME, WHICH IS GRADE IV LESION 5 YEAR SURVIVAL
|
0%
|
|
MOST COMMON FOR HEAD AND NECK CANCER
|
LARYNX
|
|
LARYNX STAGING: T1
|
TUMOR LIMITED TO VOCAL CORDS W/ NORMAL MOTILITY
|
|
LARYNX STAGING: T1A
|
TUMOR LIMITED TO ONE VOCAL CORD
|
|
LARYNX STAGING: T1B
|
TUMOR INVOLVES BOTH CORDS
|
|
LARYNX STAGING: T2
|
TUMOR EXTENDS TO SUPRAGLOTTIS AND /OR SUBGLOTTIS AND /OR WITH LIMITED VOCAL CORD MOBILITY
|
|
LARYNX STAGING: T3***
|
TUMOR LIMITED TO LARYNX WITH VOCAL CORD FIXATION
|
|
LARYNX STAGING: T4
|
TUMOR INVADES THROUGH TYROID CARTILAGE AND /OR EXTENDS TO OTHER TISSUES BEYOND THE LARYNX (IE OROPHARYNX, SOFT TISSUES OF NECK)
|
|
SMALL CELL BRAIN METS
|
INCIDENCE IS AS HIGH AS 50% AND PROJECTED TO BE AS HIGH AS 80% IN THOSE SURVIVING 5 YRS OR MORE
|
|
BREAST CA INFLAMMATORY STAGE
|
STAGE 4
|
|
BREAST CA: EXCISIONAL BX
|
REMOVAL OF ALL GROSS DISEASE WITH AXILLARY NODE SAMPLING FOLLOWED BY PRIMARY XRT
|
|
BREAST CA: MODIFIED RADICAL MASTECTOMY
|
REMOVAL OF ENTIRE BRST WITH PRESENTATION OF THE PECTORALIS MUSCLES INCLUDING AN AXILLARY NODE SAMPLING
|
|
BREAST CA: RADICAL MASTECTOMY
|
REMOVES FAT, ADJ TISSUE, MUSCLE, NODES, BRST TISSUE, AND SKIN
|
|
BREAST CA: MOST OFTEN USE AS BOOST TECHN
|
E-
|
|
BREAST CA: MOST OFTEN REOCCURANCE
|
SCAR AREA
|
|
BREAST CA: CHEMO DRUGS
|
CISPLATIN
5FU METHOTREXATE ADRIAMIOCIN |
|
MOST COMMON GI CANCER
|
COLORECTAL
|
|
COLORECTAL LABS
|
CEA (CARCINOEMBRYONIC ANTIGEN)
CBC |
|
CRITICAL STRUCTURES OF COLORECTAL
|
SML BOWELL
|
|
5YR SURVIVAL FOR ESOPHAGUS
|
LESS THAN 10%
|
|
ESOPHAGUS TX MARGINS
|
GENERALLY INCLUDE 5-6 CM SUP/INF THE LESION
|
|
PANCREATIC CA: MOST COMMON PRESENTING SYMPTOMS
|
JAUNDICE, PAIN, WEIGHT LOSS, AND ANOREXIA
|
|
PANCREATIC CA: SURGERY
|
STANDARD SURGICAL TX IS THE PANCREATODUODENECTOMY
(WHIPPLE) |
|
PANCREATIC CA: TX/ CHEMO
|
5FU WITH XRT
|
|
CERVICAL CA STAGING: STAGE 0
|
CARCINOMA IN SITU
|
|
CERVICAL CA STAGING: STAGE I
|
CONFINED TO CERVIX
|
|
CERVICAL CA STAGING: STAGE IA1
|
MINIMAL MICROSCOPIC INVASION (<3MM)
|
|
CERVICAL CA STAGING: STAGE IA2
|
LESIONS NOT DEEPER THAN 5MM OR HAVE HORIZONTAL SPREAD GREATER THAN 7MM
|
|
CERVICAL CA STAGING: STAGE IB1
|
LESIONS GREATER THAN IA1 BUT CONFINED TO CERVIX CORPUS
|
|
OVARIAN CA: DX WORKUP
|
ROUTINE LABS: CBC, BLOOD UREA NITROGEN, CREATNINE, LIVER ENZYMES, AND CA 125 LEVEL
|
|
LARGE CELLS WITH 2 OR MORE NUCLEI, EA W/ PROMINANT NUCLEUS |
REED-STERNBERG CELLS
|
|
HODGKINS STAGING: STAGE I
|
INVOLVEMENT OF A SINGLE LYMPH NODE REGION (I)
OR SINGLE EXTRALYMPHATIC ORGAN OR SITE (IE) |
|
HODGKINS STAGING: STAGE II
|
INVOLVEMENT OF 2 OR MORE LYMPH NODE REGIONS ON SAME SIDE OF DIAPHRAGM (II)
OR LOCALIZED INVOLVEMENT OF AN EXTRALYMPHATIC ORGAN OR SITE, AND OR MORE LYMPH NODE REGIONS ON THE SAME SIDE OF THE DIAPHRAGM (IIE) |
|
HODGKINS STAGING: STAGE III
|
INVOLVEMENT OF LYMPH NODE REGIONS ON BOTH SIDES OF THE DIAPHRAGM (III)
WHICH MAY ALSO ACCOMPANIED BY INVOLVEMENT OF SPLEEN (IIIS) OR LOCALIZED INVOLVEMENT OF AN EXTRALYMPHATIC ORGAN OR SITE (IIIE) OR BOTH (IIISE) |
|
HODGKINS STAGING: STAGE IV
|
DIFFUSE OR DISSEMINATED INVOLVEMENT OF ONE OR MORE EXTRALYMPHATIC ORGANS OR TISSUES, WITH OR WITHOUT ASSOCIATED NODE INVOLVEMENT
|
|
HODGKINS: "B" SYMPTOMS
|
UNEXPLAINED WEIGHT LOSS >10//5
UNEXPLAINED FEVER NIGHT SWEATS |
|
HODGKINS: CHEMO
|
MOPP OR MOPP-ABV
|
|
HODGKINS STAGES I,II,III: PRIMARY TX
|
XRT
|
|
HODGKINS: MANTLE FIELD
|
FROM INF MANDIBLE-DIAPHRAGM (T10)
|
|
HODGKINS: MANTLE FIELD: LYMPHATICS
|
ABOVE DIAPHRAGM NODES INCLUDE:
CERVICAL SUBMANDIBULAR AXILLARY SUPRACLAV INFRACLAV MEDIASTINAL HILAR NODES |
|
HODGKINS: MANTLE FIELD: BLOCKS
|
LUNG BLOCKS
OCCIPITAL REGION SPINAL CORD- POST (IF NEEDED) LARYNX- ANT HUMERAL HEADS- ANT/POST |
|
HODKINS: INVERTED Y:
|
GENERALLY TX SEPERATELY
|
|
HODGKINS: INVERTED Y: PERIAORTIC NODES
|
INCLD SPLENIC HILUM OR ENTIRE SPLEEN IF NOT REMOVED
-SHOULD MATCH MANTLE FIELD W/ ADQTE GAP AND EXT TO L4-L5 |
|
HODGKINS: INVERTED Y: LYMPH NODES
|
ILIAC NODES
FEMORAL NODES MIDLINE BLOCK- TO SPARE OVARIES (M &F) CLAM SHELL MALES TO LIMIT DOSE TO TESTES |
|
HODGKINS: TOTAL NODAL IRRADIATION:
|
MANTLE & INVERTED Y
|
|
HODGKINS TX: XRT: DOSE
|
180-200 CGY/DAY
POSITIVE NODES TO 40-45 GY |
|
WHAT MIGHT OCCUR 1 YR AFTER TX OF HODGKINS
|
FIBROSIS & BONE MARROW DEPRESSION
|
|
DISEASE OCCURS USUALLY 3 MO AFTER MANTLE XRT
|
LEHERMITES- HAND AND ARM TINGLING
|
|
USED EXCLUSIVELY TO TREAT NHL
|
CHEMO
|
|
MOST COMMON CA IN US MEN
|
PROSTATE
|
|
BEST TUMOR MARKER FOR PROSTATE CA & IMPORTANT PROGNOSTIC INDICATOR
|
PSA (SERUM AND ACID PHOSPHATASE)
ELEVATED W/ METS |
|
FULL OR EMPTY BLADDER FOR PROSTATE XRT
|
FULL
|
|
BLADDER CA LYMPH DRAINAGE
|
EXTERNAL AND INT ILIAC AND PRESACRAL LN'S
|
|
BLADDER CA HISTOLOGY
|
92% TRANSITIONAL CELL
|
|
TESTICULAR CA
|
1% OF ALL MALE CA
AVE AGE 32 15-39 YRS |
|
TESTICULAR CA: HISTOLOGY
|
SEMINOMAS
|
|
TESTICULAR CA: LAB TEST: TUMOR MARKERS
|
ALPHA FETA PROTIEN
BETA HCG CBC |
|
TESTICULAR CA: TX
|
CHEMO- CISPLATIN
|
|
TESTICULAR CA: WHEN INDICATED, SCROTOM MAY BE TX WITH E- IN SEP FIELD
|
HOCKEY STICK
|
|
2ND LEADING CAUSE OF DEATH IN CHILDREN
|
CANCER
ACCIDENTS #1 |
|
MOST COMMON CHILD CA
|
1-LEUKEMIA
2-CNS 3-LYMPHOMAS 4-SOLID TUMORS |
|
EWINGS SARCOMA: MOST OFTEN BONES EFFECTED IN LOWER HALF OF BODY
|
1-FEMUR
2-PELVIS |
|
EWINGS SARCOMA: TX:
|
SURGERY (LOWER EXT)
|
|
WILMS TUMOR
|
INVOLVES KIDNEYS
BILAT FOUND IN 5% OF CASES -ABD SWELLING |
|
WILMS TUMOR: OVERALL SURVIVAL
|
80-90%
|
|
RHABDOMYOSARCOMA
|
-HIGHLY MALIGNANT SOFT TISSUE SARCOMA
-ARISES FROM SKELETAL MUSCLE |
|
RHABDOMYOSARCOMA: SITE OCCURANCE
|
ANY SITE ON BODY
-CHILDREN H&N -ADOLESCENCE TRUNK & EXT -INFANTS BLADDER & VAGINA |
|
RHABDOMYOSARCOMA: SPREAD BY LYMPH NODES AND LOCAL INVASION: 20% @ TIME DX
|
MOST COMMONLY SEEN
LUNGS BONE MARROW |
|
BONE TUMORS
|
HIGHEST DURING ADOLESCENCE
MOST COMMON MALIGNANT IS METS OCCURING IN SPINE OR PELVIS |
|
MOST COMMON PRIMARY MALIGNANT BONE TUMOR
|
OSTEOSARCOMA
|
|
RADIORESISTANT TUMORS
|
OSTEOSARCOMA
CHONDROSARCOMA FRIBROSARCOMA |
|
RADIOSENSITIVE TUMORS
|
EWINGS SARCOMA
RETICULUM CELL LYPOSARCOMA MULTIPLE MYELOMA |
|
SOFT TISSUE SARCOMA LOCATIONS
|
1-LOWER EXT (THIGH MAINLY)
2-TRUNK 3-UPPER EXT 4-H&N |
|
SOFT TISSUE SARCOMA: TX
|
HIGH RECURRENCE RATE WITH SURGERY-ADJ XRT
1 CM STRIP (AT LEAST) IN EXT FOR LYMPHODEMA |
|
SOFT TISSUE SARCOMA: METS
|
CHEST
|
|
PITUATARY TUMORS: LOCATION
|
MIDLINE STRUCTURE: LIES IN SELLA (2M ANT & SUP FROM EAM)
|
|
PITUATARY TUMORS: XRT
|
-ARC ROTATION WITH FLYING WEDGES
-POP W/ 15* WEDGES HEELS ANT TO DECREASE DOSE TO OPTIC CHIASM |
|
PITUATARY TUMORS: XRT DOSE
|
ENERGY LOWER THAN 10 MV, VERTEX CAN BE ADDED TO DECREASE DOSE TO TEMPORAL LOBE
|
|
THYROID CA: TX
|
TOTAL THYROIDECTOMY FOLLOWED BY IODINE (I 131) TO ABLATE THE GLAND AND TREAT METS
|
|
MELIGNANT MELANOMA STAGING
|
BY DEPTH OF INVASION
CLARKS LEVEL AND LYMPH NODE INVASION AND SURVIVAL TUMOR DEPTH AND THICKNESS HAVE PROGNOSTIC SIGNIFICANCE |
|
GTV
CTV PTV |
GROSS TUMOR VOL
CLINICAL TUMOR VOL PLANNED TARGET VOL |
|
PRESCRIBED DOSE AKA
|
GIVEN DOSE
|
|
DMAX
CO60 4MV 6MV 10MV 18MV |
CO60- 0.5 CM
4MV- 1.0 CM 6MV- 1.5 CM 10MV- 2.5 CM 18MV- 3.5 CM |
|
PHOTON ENERGY: THE HIGHER THE ENERGY THE ___ THE DOSE TO SKIN
|
LOWER
|
|
E-: HIGHER ENERGY ___ DOSE TO SKIN SURFACE
|
HIGHER
|
|
HIGHER ENERGY PHOTONS HAVE ____ PDD BEYOND DMAX DEPTH
|
HIGHER
|
|
THERAPEUTIC BEAM CONSIST OF WHAT KIND OF RADIATION |
PRIMARY AND SCATTER
|
|
1 CURIE =
|
3.7 X 10^10 DISINTIGRATIONS PER SECOND
|
|
CBC: HEMOGLOBIN: OXYGEN CARRYING MOLECULE IN RBC'S
|
MEN- 13.5-18 G/DL
WOMEN- 12-16 G/DL |
|
CBC: HEMATOCRIT: MEASURE OF PACKED VOLUME OF RBC EXPRESSED AS %
|
MEN- 43-49%
WOMEN- 27-43% |
|
CBC: PLATLETS: AKA THROMBOCYTES, SMLST OF CELLS IN BLOOD
|
NORMAL VOLUME: 200,000-300,000 ML^3
STOP TX IF FALLS BELOW 60-70,000 ML^3 |
|
CBC: WBC: MOST RADIOSENSITIVE
|
5,000-10,000/ MM^3
(NEUTROPHILS, LYMPHOCYTES, MONOCYTES, EOSINOPHILS, ETC) |
|
GENERAL FUNCT OF BLOOD
|
-TRANSPORTATION
-REGULATION -PROTECTION |
|
CHEMOTHERAPY: CATEGORIES
|
ANTIMETABOLITES
ALKYLATING AGENTS ANTI-TUMOR ANTIBIOTICS VINCA ALKALOIDS HORMONES |
|
CHEMO: MOPP
|
MECHLORETHAMINE
VINCRISTINE PROCARBAZINE PREDNISONE |
|
REVERTING POST MITOTIC CELLS IN
|
LIVER
|
|
FIXED POSTMITOTIC CELLS
|
BRAIN, RBC
|
|
CATARACTS |
2-7 GY
|
|
OCCUPATIONAL EYE DOSE
|
15 REM
|
|
CNS SYNDROME DOSE |
20-50 GY
|
|
ROENTGEN: 1R=
|
2.58 X 10^-4 C/KG
|
|
NCRP
|
NATIONAL COUNCIL ON RADIATION PROTECTION AND MEASUREMENTS: RECOMMEDATIONS ON RAD PROTECTION AND UNITS
|
|
NRC
|
NUCLEAR REGULATORY COMMISSION: WHAT LAWS FOR RAD. MAY OR MAY NOT BE A AGREEMENT STATE
|
|
CO 60 DECAYS TO ___ WITH WHAT AVE ENERGY
|
NICKEL 60
1.25 MEV |
|
BASIC COMPONENTS OF LINAC
|
MODULATOR
ELECTRON GUN MAGNETRON/KLYSTRON WAVEGUIDE CIRCULATOR LOOK ACCELERATING GUIDE UP BENDING MAGNET TRANSMISSION TARGET FLATTENING FILTER MONITORING ION CHAMBERS SCATTERING FOIL |
|
WHAT BASIC COMPONENT OF A LINAC IS USE FOR PHOTONS? E-?
|
PHOTONS- FLATTENING FILTER
E- : SCATTERING FOIL |
|
WHAT GAS IS IN LINACS
|
SULFERHEXAFLOURIDE 6
SF6 |
|
CONSTANCY OF CALIBRATION MUST BE CHECKED ___ FOR LINACS ___ FOR CO 60
|
LINACS- WEEKLY
CO 60- MONTHLY |
|
LIGHT FIELD MALFUNCTION CAN BE DUE TO
|
TARGET, COLLIMATORS, LIGHT SOURCE
|
|
TELL IF MISTAKE ON PT:
IF PROBLEM W/ MACHINE |
PT: ONCOLOGIST
MACHINE: PHYSCIST |
|
IF TABLE MOVES SPONTANEOUSLY
|
EMERGENCY OFF
|
|
TAR AT THE LEVEL OF DMAX IS
|
BACKSCATTER
|
|
GTV + CTV = |
PTV
PLANNED TUMOR VOL |
|
WHAT % LINE DEFINES THE TX FIELD ON LINEAR ACCERLERATORS |
50% LINE
|
|
RADIATION UNITS
|
1 Ci= 3.7 x 10^10 Bq
1 R= .873 rad 1 Gy= 100 rad 1 cGy= 1 rad 1 Sv= 100 rem |
|
DOSE EQUIV |
ACCOUNTS FOR LET & RBE
|
|
HVL =
|
.693/ LINEAR ATTENTUATION COEFFICIENT
|
|
1 R= _________ C/KG IN AIR
|
2.58 X 10^-4 C/KG IN AIR
|
|
QUALITY OF XRAY BEAM
|
OBTAINED FROM THE AVERAGE XRAY ENERGY OF THE XRAY SPECTRUM
|
|
BEAM HARDENING REFERS TO
|
PREFERENTIAL LOSS OF LOWER ENERGY PHOTON ENERGIES, THEN AVE XRAY ENERGY IS NOW INCREASED
|
|
THE ____ THE ENERGY, THE ____ THE HVL THE MORE PENETRATING
|
HIGHER ENERGY
HIGHER HVL HIGHER PENETRATING |
|
POLYCHROMATIC?
|
FLUCTUATION OF TUBE POTENTIAL (BREMSTRAULUNG)
|
|
WHERE MOST ENERGY IS DEPOSITED AT END OF RANGE |
BRAGG PEAK
|
|
BRAGG-GRAY THEORY
|
IONIZATION PRODUCED IN A GAS FILLED CAVITY PLACED IN A MEDIUM, IT IS RELATED TO THE ENERGY ABSORBED IN THE SURROUNDING MEDIUM
|
|
COMPENSATORS
|
USED TO FILL IN GAPS DURING TX, NOT TO BE CONFUSED WITH BOLUS
|
|
INFORMED CONSENT |
NATURE OF PROCEDURE
EXPECTATIONS REASONABLE ALTERNATIVES RISKS |
|
DMAX |
BUILD UP REGION TO ALLOW TO REACH 100%
|
|
GAMMA RAYS ARE
|
NATURALLY OCCURING
|
|
BODY TEMP IS CONTROLLED BY
|
HYPOTHALAMUS
|
|
PYREXIA
|
FEVER
|
|
PULSE AREAS
|
APICAL-HEART
RADIAL CAROTID FEMORAL POPLITEAL DORSALIS PEDIS POST TIBIAL BRACHIAL |
|
ONLY STERILE GOWN AREAS |
WAIST TO SHOULDERS IN FRONT AND SLEEVES
|
|
ELIZABETH KUBLER-ROSS 5 PSYCHOLOGICAL STAGES OF DYING PT
|
DENIAL
ANGER BARGAINING DEPRESSION ACCEPTANCE |
|
TUMOR MARKER: CA 19-9 FOR |
COLORECTAL & PANCREATIC
|
|
TUMOR MARKER: PSA FOR |
PROSTATE REOCCURANCE
|
|
TUMOR MARKER: PHOSPHATASE
|
PROSTATE
|
|
TUMOR MARKER: HCG
|
GERM CELL TUMORS
PURE SEMINOMAS |
|
TUMOR MARKER: CEA
|
COLON: METS |
|
H&N ABOVE EPIGLOTTIS |
VALLECULA
|
|
WHAT ATTENUATES LEAST
|
TRAY- .9
BOLUS- 1 WEDGE- >1 |
|
ACITES ASSOCIATED WITH
|
OVARIAN CA
|
|
AORTA BRANCHES
|
CILLIAC ARTERY
SUP MESENTARY RENAL ARTERY INF MESENTARY ILLIACS |
|
GERMAN HELMET: TX CNS: |
WHOLE BRAIN PLUS C2
EYEBROWS TO MASTOID |
|
WHAT ATTACHES BOTH LOBES OF BRAIN |
CORPUS COLLOSUM
|
|
WHAT IS RIGHT ABOVE WHERE BRAIN STEM STARTS |
THALAMUS/HYPOTHALAMUS
|
|
WHAT LEVEL IS FORAMEN MAGNUM
|
C1
|
|
STEREOTACTIC IS _______ BUT CAN BE KNOCKED OUT IN 1 DAY |
SIZE DEPENDANT
|
|
PRIMARY BRAIN BORDER |
2-3 CM MARGIN, AND ALSO ENOUGH MARGIN AROUND EDEMA
|
|
WHOLE BRAIN TX |
3-4000 CGY |
|
DESCRIBE CRANIOSPINAL XRT |
KID MAINLY |
|
CNS IMAGING
|
NEEDS MRI
|
|
MEDULOBLASTOMAS & EPENDIMOMAS SPREAD
|
SEED DOWN CORD
-DIST METS RARE |
|
LYMPHOMAS ARE
|
EASY TO TREAT
|
|
PITUATARY CA IS |
RARE
|
|
TD 5/5 BRAIN
|
50 GY
|
|
MOST COMMON BRAIN IN CHILDREN
|
MEDULLOBLASTOMA
|
|
MOST COMMON CA IN CHILDREN
|
LUEKEMIA
|
|
FUNCTION OF PITUATARY GLAND
|
MASTER GLAND FOR HORMONES
AFTER TX GIVE SYNTHETIC HORMONES |
|
MOST COMMON GYN CA |
ENDOMETRIAL
|
|
TAH |
TOTAL ABD HYSTORECTOMY |
|
CERVIX LYMPH NODES |
1ST- ILLIACS
THEN PARAAORTICS |
|
MOST DEADLIST GYN CA
|
OVARIAN
|
|
UGI: LYMPH NODES |
SUPERCLAV (UPPER/MIDDLE) THEN MEDIASTINAL (LOWER) THEN CELIAC
|
|
POSITION FOR ESOPHAGUS XRT |
PRONE- PULL IT AWAY FORM CORD |
|
MOST COMMON GI |
RECTUM |
|
COMMON MET SITE: LUNG
|
LIVER |
|
COMMON MET SITE: BREAST |
LUNGS |
|
COMMON MET SITE: STOMACH
|
LIVER
|
|
COMMON MET SITE: ANUS
|
LIVER
LUNG |
|
COMMON MET SITE: BLADDER
|
LUNGS
BONE LIVER |
|
COMMON MET SITE: PROSTATE |
BONE |
|
UTERINE CERVIX
|
LUNGS
BONE LIVER |
|
DNA: PURINES
|
ADENINE
GUANINE |
|
DNA: PYRIMIDINES
|
THYMINE |
|
5 VITAL NECESSITIES BODY NEEDS TO MAINTAIN BALANCE
|
WATER
TEMP OXYGEN PH ELECTROLYTES |
|
CELL
|
UNIT OF LIFE |
|
4 TYPES OF NECROSIS
|
COAGULATIVE |
|
WHERE IS THE FIELD SIZE DEFINED
|
ISOCENTER
|
|
RADIATION BEAM IS COMPOSED OF WHAT?
WHICH IS MADE UP OF WHAT? |
PRIMARY AND SCATTER |
|
OTHER NAMES FOR DMAX |
GIVEN DOSE |
|
INTERACTION OF AXIS OF ROTATION OF GANTRY AND COLLIMATOR
|
ISOCENTER
|
|
DIST FROM SOURCE OF PHOTONS TO ISOCENTER OF TX MACHINE
|
SAD
|
|
DIST FROM SOURCE OF TX MACHINE TO SURFACE OF PT OR PHANTOM |
SSD
|
|
CALC PT (ISO) HAS TO BE ___CM AWAY FROM BLOCK FIELD DUE TO ____ |
2 CM
PENUMBRA |
|
MEASUREMENT OF PT THICKNESS FROM THE POINT OF BEAM ENTRY TO EXIT
|
SEPERATION
|
|
EFS |
EFFECTIVE FIELD SIZE |
|
3 GENERAL POINTS NEED TO PERFORM TX CALC
|
-DOSE AT POINT |
|
LENGTH OF TIME UNIT IS PHYSICALLY ON |
TX TIME
MU SETTING |
|
DIST BENEATH THE SKIN WHERE PRESCRIBED DOSE IS DELIVERED |
DEPTH
|
|
PDD IS USED FOR WHAT KIND OF TX
|
SDD (NON ISOCENTRIC)
|
|
HD "A" SYMPTOMS |
NO SYMPTOMS
|
|
THE COMBO OF SCATTER FROM FLATTENING FILTER AND COLLIMATOR
|
HEAD SCATTER
|
|
HERPES VIRUS ASSOCIATIED W/ NASOPHARYNGEAL CA & BURKITTS LYMPHOMA |
EPSTEIN-BARR VIRUS
(EBV) |
|
LARYNX
(3 AREAS) |
SUPRAGLOTTIS
GLOTTIS SUBGLOTTIS |
|
HD SUBTYPES
|
LYMPHOCYTE PREDOMINANT
NODULAR SCHLEROSIS MIXED CELLULANT LYMPHOCYTE DEPLETION |
|
SMALL CELL LUNG CA ALSO CALLED
|
OAT CELL
-PROPHYLACTIC XRT TO BRAIN |
|
LRGST LYMPH ORGAN |
SPLEEN
|
|
WHAT KIND OF CA IS MYCOSIS FUNGOIDES? |
LYMPHOMAS |
|
LIPS CONTROLLED BY
|
ORBICULARIS ORIS MUSCLE
AKA VERMILLION |
|
ORAL CAVITY DIVIDED BY
|
ANT 2/3 ORAL TONGUE
POST 2/3 BASE TONGUE |
|
MOST COMMON ORAL CAVITY CA |
LIP CA |
|
PAROTID DRAINS BY
|
STENTSENS DUCT
|
|
KAPOSI'S SARCOMA ASSOCIATED WITH |
AIDS |
|
DISEASE OF THE ELDERLY 65+
|
SQUAMOUS CELL CA
|
|
HD W/ LIVER INVOLVEMENT |
ALWAYS STAGE IV
|
|
HD: LYMPH STRUCTURES
|
LYMPH NODES
SPLEEN THYMUS WALDEYERS RING APPENDIX PEYERS PATCHES |
|
ONLY CA TRULY CONSIDERED GENETICALLY TRANSMITTED |
NEUROBLASTOM OF THE RETINA
|
|
SYNERGEISTIC INTERACTION
|
ADDING CIGARRETTS (21X) OR ASBESTOS (7X) INCREASES CHANCES
|
|
PROMOTION
|
SECOND EXPOSURE
|
|
PORT WINE STAIN OR BIRTHMARK
|
ANGIOMA
|
|
FAMILY TENDANCIES IN DEVELOPING CA (3)
|
BRST CA
FAMILIAR POLYPOSIS XERODERMA PIGMENTOSUM |
|
PATHALOGICAL STAGING FOR HD
|
STAGING LAPRATOMY
REMOVAL OF SPLEEN LIVER BX @ 3 SITES REMOVAL OF SUSPECT ABD LYMPH NODES |
|
PITUITARY GLAND LOCATED |
IN THE SELLA TURCIA
2 CM ANT 2 CM SUP FROM EAM "MASTER GLAND" |
|
ADRENAL GLANDS SIT
|
ON TOP ON THE KIDNEYS
|
|
CORTICOSTEROIDS ARE
|
ANTI-INFLAMMATORY AND PERSCRIBED FOR BRAIN TX
|
|
PANCREAS SECRETES |
INSULIN
|
|
WHAT STAGE OF CERVIX CANCER? BEYOND THE UTERUS, BUT NOT IN THE PELVIC WALL OR THE LOWER 1/3 OF THE VAGINA WITHOUT PARAMETRIAL INVASION |
T2a, NO,MO
|
|
WHAT KIND ON STAGING IS USED IN UTERINE CERCVIX CA
|
FIGO
|
|
WHAT KIND OF STAGING IS USED FOR LARYNX CA
|
TNM |
|
WHAT KIND OF STAGING IS USED IN HODGKINS DISEASE |
ANN ARBOR
|
|
DIRECT ACTION: 18 MV, ALPHA, NEUTRONS: |
LIKELY TO HAPPEN WITH HIGH LET
DAMAGES DNA DIRECTLY |
|
INDIRECT EXPOSURE: 6MV, GAMMA, XRAYS: |
MOST COMMON REACTION |
|
WHAT IS PRODUCED THRU IONIZATION OF H20 |
FREE RADICAL |
|
IN LET RADIATIONS, GENERALLY AS LET INCREASES, RBE (RELATIVE BIOLOGICAL EFFECTIVENESS)____ |
INCREASES |
|
WHAT ARE THE 3 THINGS THAT HAPPEN TO CELLS AFTER IRRADIATION |
1. DIVISION DELAY
2. INTERPHASE DEATH 3. REPRODUCTIVE FAILURE |
|
*EARLY* RESPONDING NORMAL TISSUE MANIFEST INJURY WITHIN
|
A FEW MONTHS OF RADIATION COMPLETED
|
|
*LATE* RESPONDING NORMAL TISSUE MANIFEST INJURY WITHIN |
3 MONTHS OR LONGER
(LUNG, CNS, KIDNEY, LIVER) |
|
CAN A PACEMAKER BE IN THE TX FIELD
|
NO
MAX DOSE IS 250CGY |
|
NTTD |
TOLERANCE DOSES ESTABLISHED FOR NORMAL TISSUES FOR THE TOTAL DOSE DELIVERED BY A STANDARD FX SCEDULE THAT CAUSES COMPLICATIONS RATE WITHIN 5 YEARS
|
|
IF A WEDGE IS LEFT OUT OR IT CALLED FOR 30* AND A 15* WAS IN DURING TX, THE PATIENT WOULD BE |
OVERDOSED
|
|
WHAT IS MOST TOXIC IN CERROBEND
|
CADMIUM |
|
HVL |
INCREASE IN THICKNESS AFTER THE 1ST HVL DUE TO BEAM HARDENING (MEANING A THICKER PIECE TO COMPENSATE SINCE THE BEAM GETS HARDENED AFTER THE 1ST HVL) |
|
COORDINATES |
X: TRANSVERSE
Y: SAGGITAL Z: CORONAL |
|
PHOTOELECTRIC EFFECT IS WHEN A PHOTON INTERACTS WITH |
AN INNER SHELL ELECTRON
|
|
IN BREMSSTRAHLUNG A HIGH SPEED E- INTERACTS WITH |
THE ELECTROSTATIC FIELD OF A NUCLEUS
BRAKING E- |
|
CELSIUS |
C# X 9 /5 +32 =
F# -32 X5 /9 = |
|
SPLIT FIELD TEST FOR BEAM ALIGNMENT USES |
|
|
CNS MOSTLY COMPOSED OF _____ |
CNS COMPOSED OF WHITE MATTER |
|
LARGEST ORGAN OF THE BODY
|
SKIN
|
|
MAJOR VEIN THAT EMPTIES BLOOD INTO THE HEART |
SVC
|